BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262:509-525. [PMID: 17949362 DOI: 10.1111/j.1365-2796.2007.01844.x] [Cited by in Crossref: 491] [Cited by in F6Publishing: 432] [Article Influence: 35.1] [Reference Citation Analysis]
Number Citing Articles
1 Vadalà G, Sowa G, Hubert M, Gilbertson LG, Denaro V, Kang JD. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation. J Tissue Eng Regen Med. 2012;6:348-355. [PMID: 21671407 DOI: 10.1002/term.433] [Cited by in Crossref: 162] [Cited by in F6Publishing: 147] [Article Influence: 16.2] [Reference Citation Analysis]
2 Weng JY, Du X, Geng SX, Peng YW, Wang Z, Lu ZS, Wu SJ, Luo CW, Guo R, Ling W. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant. 2010;45:1732-1740. [PMID: 20818445 DOI: 10.1038/bmt.2010.195] [Cited by in Crossref: 168] [Cited by in F6Publishing: 142] [Article Influence: 15.3] [Reference Citation Analysis]
3 Barhum Y, Gai-Castro S, Bahat-Stromza M, Barzilay R, Melamed E, Offen D. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci 2010;41:129-37. [PMID: 19902385 DOI: 10.1007/s12031-009-9302-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
4 Yu SJ, Kim HJ, Lee ES, Park CG, Cho SJ, Jeon SH. β-Catenin Accumulation Is Associated With Increased Expression of Nanog Protein and Predicts Maintenance of MSC Self-Renewal. Cell Transplant 2017;26:365-77. [PMID: 27684957 DOI: 10.3727/096368916X693040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
5 Holan V, Javorkova E. Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction. Stem Cell Rev Rep. 2013;9:609-619. [PMID: 23733704 DOI: 10.1007/s12015-013-9449-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
6 Hao L, Sun H, Wang J, Wang T, Wang M, Zou Z. Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis. Int J Hematol. 2012;95:34-46. [PMID: 22183780 DOI: 10.1007/s12185-011-0991-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
7 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zangi L, Margalit R, Reich-zeliger S, Bachar-lustig E, Beilhack A, Negrin R, Reisner Y. Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells. Stem Cells 2009;27:2865-74. [DOI: 10.1002/stem.217] [Cited by in Crossref: 169] [Cited by in F6Publishing: 149] [Article Influence: 14.1] [Reference Citation Analysis]
9 Meretoja VV, Dahlin RL, Kasper FK, Mikos AG. Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials 2012;33:6362-9. [PMID: 22695067 DOI: 10.1016/j.biomaterials.2012.05.042] [Cited by in Crossref: 139] [Cited by in F6Publishing: 121] [Article Influence: 15.4] [Reference Citation Analysis]
10 Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells. 2011;3:25-33. [PMID: 21607134 DOI: 10.4252/wjsc.v3.i4.25] [Cited by in Crossref: 151] [Cited by in F6Publishing: 136] [Article Influence: 15.1] [Reference Citation Analysis]
11 Machhi J, Shahjin F, Das S, Patel M, Abdelmoaty MM, Cohen JD, Singh PA, Baldi A, Bajwa N, Kumar R, Vora LK, Patel TA, Oleynikov MD, Soni D, Yeapuri P, Mukadam I, Chakraborty R, Saksena CG, Herskovitz J, Hasan M, Oupicky D, Das S, Donnelly RF, Hettie KS, Chang L, Gendelman HE, Kevadiya BD. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J Neuroimmune Pharmacol 2021;16:270-88. [PMID: 33544324 DOI: 10.1007/s11481-020-09981-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang BC, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 2011;9:181. [PMID: 22017805 DOI: 10.1186/1479-5876-9-181] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 9.2] [Reference Citation Analysis]
13 Huang CP, Yang CY, Shyr CR. Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases. Cell Transplant 2021;30:9636897211011995. [PMID: 33975464 DOI: 10.1177/09636897211011995] [Reference Citation Analysis]
14 Cutler AJ, Limbani V, Girdlestone J, Navarrete CV. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol. 2010;185:6617-6623. [PMID: 20980628 DOI: 10.4049/jimmunol.1002239] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 10.6] [Reference Citation Analysis]
15 Otsuru S, Hofmann TJ, Olson TS, Dominici M, Horwitz EM. Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy 2013;15:146-53. [DOI: 10.1016/j.jcyt.2012.10.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
16 Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther. 2010;18:1365-1372. [PMID: 20389289 DOI: 10.1038/mt.2010.54] [Cited by in Crossref: 122] [Cited by in F6Publishing: 109] [Article Influence: 11.1] [Reference Citation Analysis]
17 Mohammadian M, Sadeghipour HR, Jahromi GP, Jafari M, Nejad AK, Khamse S, Boskabady MH. Simvastatin and bone marrow-derived mesenchymal stem cells (BMSCs) affects serum IgE and lung cytokines levels in sensitized mice. Cytokine 2019;113:83-8. [PMID: 29914792 DOI: 10.1016/j.cyto.2018.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sundin M, Remberger M, Lönnies H, Sundberg B, Ringdén O, Le Blanc K. No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells. Cytotherapy 2008;10:238-42. [PMID: 18418769 DOI: 10.1080/14653240801965164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Bahrehbar K, Rezazadeh Valojerdi M, Esfandiari F, Fathi R, Hassani SN, Baharvand H. Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure. World J Stem Cells 2020;12:857-78. [PMID: 32952863 DOI: 10.4252/wjsc.v12.i8.857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sadan O, Shemesh N, Barzilay R, Bahat-stromza M, Melamed E, Cohen Y, Offen D. Migration of Neurotrophic Factors-Secreting Mesenchymal Stem Cells Toward a Quinolinic Acid Lesion as Viewed by Magnetic Resonance Imaging: MIGRATION OF NEUROTROPHIC FACTORS-SECRETING MESENCHYMAL STEM CELLS TOWARD A QUINOLINIC ACID LESION AS VIEWED BY MAGNETIC RESONANCE IMAGING. STEM CELLS 2008;26:2542-51. [DOI: 10.1634/stemcells.2008-0240] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
21 Piper SL, Wang M, Yamamoto A, Malek F, Luu A, Kuo AC, Kim HT. Inducible immortality in hTERT-human mesenchymal stem cells. J Orthop Res. 2012;30:1879-1885. [PMID: 22674533 DOI: 10.1002/jor.22162] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
22 He F, Yu C, Liu T, Jia H. Ginsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells. Front Pharmacol 2019;10:1565. [PMID: 32038244 DOI: 10.3389/fphar.2019.01565] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
23 Touboul C, Vidal F, Pasquier J, Lis R, Rafii A. Role of mesenchymal cells in the natural history of ovarian cancer: a review. J Transl Med 2014;12:271. [PMID: 25303976 DOI: 10.1186/s12967-014-0271-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
24 Ren J, Jin P, Sabatino M, Balakumaran A, Feng J, Kuznetsov SA, Klein HG, Robey PG, Stroncek DF. Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency. Cytotherapy. 2011;13:661-674. [PMID: 21250865 DOI: 10.3109/14653249.2010.548379] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
25 Chhabra P, Mirmira RG, Brayman KL. Regenerative medicine and tissue engineering: contribution of stem cells in organ transplantation. Current Opinion in Organ Transplantation 2009;14:46-50. [DOI: 10.1097/mot.0b013e328322f989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10:709-716. [PMID: 22704511 DOI: 10.1016/j.stem.2012.05.015] [Cited by in Crossref: 508] [Cited by in F6Publishing: 462] [Article Influence: 56.4] [Reference Citation Analysis]
27 Burr A, Parekkadan B. Kinetics of MSC-based enzyme therapy for immunoregulation. J Transl Med 2019;17:263. [PMID: 31409424 DOI: 10.1186/s12967-019-2000-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Meretoja VV, Dahlin RL, Wright S, Kasper FK, Mikos AG. The effect of hypoxia on the chondrogenic differentiation of co-cultured articular chondrocytes and mesenchymal stem cells in scaffolds. Biomaterials 2013;34:4266-73. [PMID: 23489925 DOI: 10.1016/j.biomaterials.2013.02.064] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 11.1] [Reference Citation Analysis]
29 Hermankova B, Kossl J, Javorkova E, Bohacova P, Hajkova M, Zajicova A, Krulova M, Holan V. The Identification of Interferon-γ as a Key Supportive Factor for Retinal Differentiation of Murine Mesenchymal Stem Cells. Stem Cells Dev 2017;26:1399-408. [PMID: 28728472 DOI: 10.1089/scd.2017.0111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Yu H, Adesida AB, Jomha NM. Meniscus repair using mesenchymal stem cells - a comprehensive review. Stem Cell Res Ther 2015;6:86. [PMID: 25925426 DOI: 10.1186/s13287-015-0077-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
31 Ricordi C, Inverardi L, Domínguez-bendala J. From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes. Regenerative Medicine 2012;7:41-8. [DOI: 10.2217/rme.12.70] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
32 Ionescu LI, Alphonse RS, Arizmendi N, Morgan B, Abel M, Eaton F, Duszyk M, Vliagoftis H, Aprahamian TR, Walsh K, Thébaud B. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol 2012;46:207-16. [PMID: 21903873 DOI: 10.1165/rcmb.2010-0391OC] [Cited by in Crossref: 49] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
33 Rad F, Ghorbani M, Mohammadi Roushandeh A, Habibi Roudkenar M. Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles. Mol Biol Rep. 2019;46:1533-1549. [PMID: 30623280 DOI: 10.1007/s11033-019-04588-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 16.0] [Reference Citation Analysis]
34 Crapnell K, Blaesius R, Hastings A, Lennon DP, Caplan AI, Bruder SP. Growth, differentiation capacity, and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Experimental Cell Research 2013;319:1409-18. [DOI: 10.1016/j.yexcr.2013.04.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
35 Schildberg FA, Hegenbarth SI, Schumak B, Scholz K, Limmer A, Knolle PA. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol. 2008;38:957-967. [PMID: 18383043 DOI: 10.1002/eji.200738060] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
36 Rodrigues MC, Rodrigues AA, Glover LE, Voltarelli J, Borlongan CV. Peripheral nerve repair with cultured schwann cells: getting closer to the clinics. ScientificWorldJournal. 2012;2012:413091. [PMID: 22701355 DOI: 10.1100/2012/413091] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
37 Ringdén O, Erkers T, Nava S, Uzunel M, Iwarsson E, Conrad R, Westgren M, Mattsson J, Kaipe H. Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease. Stem Cells 2013;31:592-601. [PMID: 23307526 DOI: 10.1002/stem.1314] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 9.9] [Reference Citation Analysis]
38 Tani C, Vagnani S, Carli L, Querci F, Kühl AA, Spieckermann S, Cieluch CP, Pacini S, Fazzi R, Mosca M. Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus. Int J Stem Cells 2017;10:160-8. [PMID: 29186654 DOI: 10.15283/ijsc17014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
39 Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev 2008;4:27-49. [PMID: 18288619 DOI: 10.1007/s12015-008-9008-2] [Cited by in Crossref: 118] [Cited by in F6Publishing: 94] [Article Influence: 9.1] [Reference Citation Analysis]
40 Pezato R, de Almeida DC, Bezerra TF, Silva Fde S, Perez-Novo C, Gregório LC, Voegels RL, Câmara NO, Bachert C. Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment. Mediators Inflamm 2014;2014:583409. [PMID: 24707116 DOI: 10.1155/2014/583409] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
41 Weiss ML, López Y, Mcintosh KR. Wharton’s Jelly-Derived Mesenchymal Stromal Cells as Immunoregulatory Cells. In: Bhattacharya N, Stubblefield P, editors. Human Fetal Tissue Transplantation. London: Springer; 2013. pp. 87-105. [DOI: 10.1007/978-1-4471-4171-6_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Fu X, Jiang B, Zheng B, Yan Y, Wang J, Duan Y, Li S, Yan L, Wang H, Chen B, Sang X, Ji W, Xu RH, Si W. Heterogenic transplantation of bone marrow-derived rhesus macaque mesenchymal stem cells ameliorates liver fibrosis induced by carbon tetrachloride in mouse. PeerJ. 2018;6:e4336. [PMID: 29456886 DOI: 10.7717/peerj.4336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
43 Porrett PM, Hashmi SK, Shaked A. Immunosuppression: trends and tolerance? Clin Liver Dis 2014;18:687-716. [PMID: 25017084 DOI: 10.1016/j.cld.2014.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
44 Gregorini M, Bosio F, Rocca C, Corradetti V, Valsania T, Pattonieri EF, Esposito P, Bedino G, Collesi C, Libetta C. Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation. BMC Immunol. 2014;15:44. [PMID: 25277788 DOI: 10.1186/s12865-014-0044-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
45 Abumoawad A, Saad A, Ferguson CM, Eirin A, Herrmann SM, Hickson LJ, Goksu BB, Bendel E, Misra S, Glockner J, Dietz AB, Lerman LO, Textor SC. In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure. Kidney Int 2020;97:793-804. [PMID: 32093917 DOI: 10.1016/j.kint.2019.11.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
46 Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton’s Jelly and bone marrow sources. Cell Immunol. 2010;264:171-179. [PMID: 20619400 DOI: 10.1016/j.cellimm.2010.06.006] [Cited by in Crossref: 168] [Cited by in F6Publishing: 157] [Article Influence: 15.3] [Reference Citation Analysis]
47 Goren A, Dahan N, Goren E, Baruch L, Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J 2010;24:22-31. [PMID: 19726759 DOI: 10.1096/fj.09-131888] [Cited by in Crossref: 102] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
48 Evans JR, Mason SL, Barker RA. Current status of clinical trials of neural transplantation in Parkinson's disease. Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I. Elsevier; 2012. pp. 169-98. [DOI: 10.1016/b978-0-444-59575-1.00008-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
49 Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept. J Clin Invest. 2010;120:41-50. [PMID: 20051635 DOI: 10.1172/jci41004] [Cited by in Crossref: 430] [Cited by in F6Publishing: 251] [Article Influence: 39.1] [Reference Citation Analysis]
50 Das MK, Lunavat TR, Miletic H, Hossain JA. The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment. Adv Exp Med Biol 2021;1326:139-57. [PMID: 33615422 DOI: 10.1007/5584_2021_619] [Reference Citation Analysis]
51 Nesselmann C, Ma N, Bieback K, Wagner W, Ho A, Konttinen YT, Zhang H, Hinescu ME, Steinhoff G. Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008;12:1795-1810. [PMID: 18684237 DOI: 10.1111/j.1582-4934.2008.00457.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 6.4] [Reference Citation Analysis]
52 Yeung TY, Seeberger KL, Kin T, Adesida A, Jomha N, Shapiro AM, Korbutt GS. Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One 2012;7:e38189. [PMID: 22666480 DOI: 10.1371/journal.pone.0038189] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
53 Najar M, Raicevic G, Id Boufker H, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol 2010;38:922-32. [PMID: 20570633 DOI: 10.1016/j.exphem.2010.05.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
54 Kosaric N, Kiwanuka H, Gurtner GC. Stem cell therapies for wound healing. Expert Opin Biol Ther. 2019;19:575-585. [PMID: 30900481 DOI: 10.1080/14712598.2019.1596257] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 21.0] [Reference Citation Analysis]
55 McIntosh KR, Lopez MJ, Borneman JN, Spencer ND, Anderson PA, Gimble JM. Immunogenicity of allogeneic adipose-derived stem cells in a rat spinal fusion model. Tissue Eng Part A 2009;15:2677-86. [PMID: 19207041 DOI: 10.1089/ten.TEA.2008.0566] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
56 Zhang M, Sun L, Wang X, Chen S, Kong Y, Liu N, Chen Y, Jia Q, Zhang L, Zhang L. Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK—ERK Signaling Pathway. Cell Transplant 2014;23:1061-73. [DOI: 10.3727/096368913x666999] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
57 García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R, Menendez P. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med 2008;12:2552-65. [PMID: 19210755 DOI: 10.1111/j.1582-4934.2008.00516.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
58 Reinders ME, Fibbe WE, Rabelink TJ. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 2010;25:17-24. [PMID: 19861311 DOI: 10.1093/ndt/gfp552] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
59 Kim M, Hwang S, Park K, Kim SY, Lee YK, Lee DS. Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes. PLoS One 2015;10:e0120602. [PMID: 25803272 DOI: 10.1371/journal.pone.0120602] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
60 Pontikoglou C, Deschaseaux F, Sensebé L, Papadaki HA. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 2011;7:569-589. [PMID: 21249477 DOI: 10.1007/s12015-011-9228-8] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 10.6] [Reference Citation Analysis]
61 Pawitan JA. Future Research in Adipose Stem Cell Engineering. In: Illouz Y, Sterodimas A, editors. Adipose Stem Cells and Regenerative Medicine. Berlin: Springer Berlin Heidelberg; 2011. pp. 257-72. [DOI: 10.1007/978-3-642-20012-0_23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Hernández-Monjaraz B, Santiago-Osorio E, Ledesma-Martínez E, Aguiñiga-Sánchez I, Sosa-Hernández NA, Mendoza-Núñez VM. Dental Pulp Mesenchymal Stem Cells as a Treatment for Periodontal Disease in Older Adults. Stem Cells Int 2020;2020:8890873. [PMID: 32908546 DOI: 10.1155/2020/8890873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
63 El Haddad N, Moore R, Heathcote D, Mounayar M, Azzi J, Mfarrej B, Batal I, Ting C, Atkinson M, Sayegh MH, Ashton-Rickardt PG, Abdi R. The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells. J Immunol 2011;187:2252-60. [PMID: 21795594 DOI: 10.4049/jimmunol.1003981] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
64 Ou-Yang HF, Huang Y, Hu XB, Wu CG. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med (Maywood) 2011;236:1461-7. [PMID: 22114062 DOI: 10.1258/ebm.2011.011221] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
65 Hu KX, Wang MH, Fan C, Wang L, Guo M, Ai HS. CM-DiI labeled mesenchymal stem cells homed to thymus inducing immune recovery of mice after haploidentical bone marrow transplantation. Int Immunopharmacol 2011;11:1265-70. [PMID: 21530684 DOI: 10.1016/j.intimp.2011.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
66 Luz-crawford P, Torres MJ, Noël D, Fernandez A, Toupet K, Alcayaga-miranda F, Tejedor G, Jorgensen C, Illanes SE, Figueroa FE, Djouad F, Khoury M. The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases: Immunosuppresive Signature of MenSC. Stem Cells 2016;34:456-69. [DOI: 10.1002/stem.2244] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
67 Tomchuck SL, Norton EB, Garry RF, Bunnell BA, Morris CA, Freytag LC, Clements JD. Mesenchymal stem cells as a novel vaccine platform. Front Cell Infect Microbiol. 2012;2:140. [PMID: 23162801 DOI: 10.3389/fcimb.2012.00140] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
68 Senegaglia AC, Rebelatto CLK, Franck CL, Lima JS, Boldrini-Leite LM, Daga DR, Leitão CA, Shigunov P, de Azambuja AP, Bana E, Marsaro DB, Schaidt B, Micosky A, Jamur VR, Schluga Y, Vaz IM, Ribeiro LL, Correa A, Brofman EPRS. Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report. Cell Transplant 2021;30:9636897211021008. [PMID: 34074163 DOI: 10.1177/09636897211021008] [Reference Citation Analysis]
69 Kurtzberg J, Prockop S, Chaudhury S, Horn B, Nemecek E, Prasad V, Satwani P, Teira P, Hayes J, Burke E;  MSB-275 Study Group. Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children. Biol Blood Marrow Transplant. 2020;26:855-864. [PMID: 32044400 DOI: 10.1016/j.bbmt.2020.01.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 18.0] [Reference Citation Analysis]
70 Ren J, Stroncek DF, Zhao Y, Jin P, Castiello L, Civini S, Wang H, Feng J, Tran K, Kuznetsov SA, Robey PG, Sabatino M. Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence. Stem Cell Res. 2013;11:1060-1073. [PMID: 23959330 DOI: 10.1016/j.scr.2013.07.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
71 Behfar A, Terzic A. Mesenchymal stem cells: engineering regeneration. Clin Transl Sci 2008;1:34-5. [PMID: 20443816 DOI: 10.1111/j.1752-8062.2008.00024.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
72 Hu C, Li L. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation. J Transl Med. 2019;17:412. [PMID: 31823784 DOI: 10.1186/s12967-019-02167-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
73 Singer W, Dietz AB, Zeller AD, Gehrking TL, Schmelzer JD, Schmeichel AM, Gehrking JA, Suarez MD, Sletten DM, Minota Pacheco KV, Coon EA, Sandroni P, Benarroch EE, Fealey RD, Matsumoto JY, Bower JH, Hassan A, McKeon A, Windebank AJ, Mandrekar JN, Low PA. Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy. Neurology 2019;93:e77-87. [PMID: 31152011 DOI: 10.1212/WNL.0000000000007720] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
74 Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS, Shin IS, Ra JC, Oh S, Yoon KS. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32:1254-1266. [PMID: 24449146 DOI: 10.1002/stem.1634] [Cited by in Crossref: 477] [Cited by in F6Publishing: 399] [Article Influence: 68.1] [Reference Citation Analysis]
75 Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, Sentís J, Sánchez A, García-Sancho J. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013;95:1535-1541. [PMID: 23680930 DOI: 10.1097/tp.0b013e318291a2da] [Cited by in Crossref: 278] [Cited by in F6Publishing: 124] [Article Influence: 34.8] [Reference Citation Analysis]
76 Neofytou E, Deuse T, Beygui RE, Schrepfer S. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties. Transplantation 2015;99:1113-8. [PMID: 26035274 DOI: 10.1097/TP.0000000000000734] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
77 Frausin S, Viventi S, Verga Falzacappa L, Quattromani MJ, Leanza G, Tommasini A, Valencic E. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem 2015;117:329-38. [PMID: 25747736 DOI: 10.1016/j.acthis.2015.02.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
78 Herzig MC, Delavan CP, Jensen KJ, Cantu C, Montgomery RK, Christy BA, Cap AP, Bynum JA. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity. J Immunol Methods 2021;488:112915. [PMID: 33212091 DOI: 10.1016/j.jim.2020.112915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 El-Jawhari JJ, El-Sherbiny Y, McGonagle D, Jones E. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors? Front Immunol 2021;12:643170. [PMID: 33732263 DOI: 10.3389/fimmu.2021.643170] [Reference Citation Analysis]
80 Leal A, Ichim TE, Marleau AM, Lara F, Kaushal S, Riordan NH. Immune effects of mesenchymal stem cells: Implications for Charcot–Marie–Tooth disease. Cellular Immunology 2008;253:11-5. [DOI: 10.1016/j.cellimm.2008.06.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
81 Hsiao CH, Ji AT, Chang CC, Cheng CJ, Lee LM, Ho JH. Local injection of mesenchymal stem cells protects testicular torsion-induced germ cell injury. Stem Cell Res Ther 2015;6:113. [PMID: 26025454 DOI: 10.1186/s13287-015-0079-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
82 Shih DT, Burnouf T. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. N Biotechnol. 2015;32:199-211. [PMID: 24929129 DOI: 10.1016/j.nbt.2014.06.001] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 14.1] [Reference Citation Analysis]
83 Ashur C, Frishman WH. Cardiosphere-Derived Cells and Ischemic Heart Failure. Cardiol Rev 2018;26:8-21. [PMID: 29206745 DOI: 10.1097/CRD.0000000000000173] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
84 Niknazar S, Abbaszadeh HA, Peyvandi H, Rezaei O, Forooghirad H, Khoshsirat S, Peyvandi AA. Protective effect of [Pyr1]-apelin-13 on oxidative stress-induced apoptosis in hair cell-like cells derived from bone marrow mesenchymal stem cells. Eur J Pharmacol 2019;853:25-32. [PMID: 30876980 DOI: 10.1016/j.ejphar.2019.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
85 Stamm C, Nasseri B, Choi YH, Hetzer R. Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ 2009;18:245-56. [PMID: 19119076 DOI: 10.1016/j.hlc.2008.10.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
86 Si YL, Zhao YL, Hao HJ, Fu XB, Han WD. MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev. 2011;10:93-103. [PMID: 20727988 DOI: 10.1016/j.arr.2010.08.005] [Cited by in Crossref: 131] [Cited by in F6Publishing: 116] [Article Influence: 11.9] [Reference Citation Analysis]
87 Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 2008;57:1759-1767. [PMID: 18586907 DOI: 10.2337/db08-0180] [Cited by in Crossref: 324] [Cited by in F6Publishing: 278] [Article Influence: 24.9] [Reference Citation Analysis]
88 Maziarz RT, Devos T, Bachier CR, Goldstein SC, Leis JF, Devine SM, Meyers G, Gajewski JL, Maertens J, Deans RJ, Van't Hof W, Lazarus HM. Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial. Biol Blood Marrow Transplant 2015;21:720-8. [PMID: 25555450 DOI: 10.1016/j.bbmt.2014.12.025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]
89 Sánchez-muñoz I, Granados R, Holguín Holgado P, García-vela JA, Casares C, Casares M. The Use of Adipose Mesenchymal Stem Cells and Human Umbilical Vascular Endothelial Cells on a Fibrin Matrix for Endothelialized Skin Substitute. Tissue Engineering Part A 2015;21:214-23. [DOI: 10.1089/ten.tea.2013.0626] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
90 Samal J, Segura T. Injectable biomaterial shuttles for cell therapy in stroke. Brain Res Bull 2021;176:25-42. [PMID: 34391821 DOI: 10.1016/j.brainresbull.2021.08.002] [Reference Citation Analysis]
91 Ersvaer E, Hatfield KJ, Reikvam H, Bruserud O. Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies. Bone Marrow Res 2011;2011:570796. [PMID: 22046566 DOI: 10.1155/2011/570796] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
92 Reich CM, Raabe O, Wenisch S, Bridger PS, Kramer M, Arnhold S. Isolation, culture and chondrogenic differentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells--a comparative study. Vet Res Commun. 2012;36:139-148. [PMID: 22392598 DOI: 10.1007/s11259-012-9523-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
93 Thomas H, Jäger M, Mauel K, Brandau S, Lask S, Flohé SB. Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion. Mediators Inflamm. 2014;2014:143463. [PMID: 24876666 DOI: 10.1155/2014/143463] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
94 An Y, wei W, Jing H, Ming L, Liu S, Jin Y. Bone marrow mesenchymal stem cell aggregate: an optimal cell therapy for full-layer cutaneous wound vascularization and regeneration. Sci Rep 2015;5:17036. [PMID: 26594024 DOI: 10.1038/srep17036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
95 Yin Z, Wang Q, Li Y, Wei H, Shi J, Li A. A novel method for banking stem cells from human exfoliated deciduous teeth: lentiviral TERT immortalization and phenotypical analysis. Stem Cell Res Ther 2016;7:50. [PMID: 27044500 DOI: 10.1186/s13287-016-0309-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
96 Foley L, Whitaker M. Concise review: cell therapies: the route to widespread adoption. Stem Cells Transl Med 2012;1:438-47. [PMID: 23197823 DOI: 10.5966/sctm.2011-0009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
97 Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes. Diabetes Metab. 2009;35:85-93. [PMID: 19230736 DOI: 10.1016/j.diabet.2008.10.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 68] [Article Influence: 7.6] [Reference Citation Analysis]
98 Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, Farwell G, Kuhn M, Nolta JA, Anderson JD. Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation. Biochem Biophys Res Commun. 2019;512:729-735. [PMID: 30926165 DOI: 10.1016/j.bbrc.2019.03.119] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 20.0] [Reference Citation Analysis]
99 Davidson PA, Bland DS, Henderson M. A systematic review of the treatment of knee osteoarthritis with intraarticular injection of mesenchymal stem cells. Current Orthopaedic Practice 2018;29:590-6. [DOI: 10.1097/bco.0000000000000694] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Gonzalez R, Griparic L, Vargas V, Burgee K, Santacruz P, Anderson R, Schiewe M, Silva F, Patel A. A putative mesenchymal stem cells population isolated from adult human testes. Biochemical and Biophysical Research Communications 2009;385:570-5. [DOI: 10.1016/j.bbrc.2009.05.103] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
101 Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol. 2011;164:1-8. [PMID: 21352202 DOI: 10.1111/j.1365-2249.2011.04327.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 151] [Article Influence: 17.2] [Reference Citation Analysis]
102 Syedain ZH, Bradee AR, Kren S, Taylor DA, Tranquillo RT. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A 2013;19:759-69. [PMID: 23088577 DOI: 10.1089/ten.TEA.2012.0365] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
103 Hur J, Kang JY, Kim YK, Lee SY, Jeon S, Kim Y, Jung CK, Rhee CK. Evaluation of Human MSCs Treatment Frequency on Airway Inflammation in a Mouse Model of Acute Asthma. J Korean Med Sci 2020;35:e188. [PMID: 32537953 DOI: 10.3346/jkms.2020.35.e188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Forslöw U, Blennow O, LeBlanc K, Ringdén O, Gustafsson B, Mattsson J, Remberger M. Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2012;89:220-227. [PMID: 22765507 DOI: 10.1111/j.1600-0609.2012.01824.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
105 Seguin A, Baccari S, Holder-Espinasse M, Bruneval P, Carpentier A, Taylor DA, Martinod E. Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement. J Thorac Cardiovasc Surg 2013;145:1297-1304.e2. [PMID: 23111025 DOI: 10.1016/j.jtcvs.2012.09.079] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
106 Hmadcha A, Domínguez-Bendala J, Wakeman J, Arredouani M, Soria B. The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med 2009;13:1464-75. [PMID: 19583810 DOI: 10.1111/j.1582-4934.2009.00837.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
107 Futrega K, Lott WB, Doran MR. Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice. Sci Rep 2016;6:23886. [PMID: 27065210 DOI: 10.1038/srep23886] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
108 Caplan AI. What's in a name? Tissue Eng Part A. 2010;16:2415-2417. [PMID: 20412005 DOI: 10.1089/ten.tea.2010.0216] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
109 Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS, Rey-Parra GJ, Weissmann G, Hall A, Eaton F, Thébaud B. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol. 2012;303:L967-L977. [PMID: 23023971 DOI: 10.1152/ajplung.00144.2011] [Cited by in Crossref: 189] [Cited by in F6Publishing: 181] [Article Influence: 21.0] [Reference Citation Analysis]
110 Saldanha-Araujo F, Melgaço Garcez E, Silva-Carvalho AE, Carvalho JL. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment. Front Immunol 2020;11:1563. [PMID: 32719683 DOI: 10.3389/fimmu.2020.01563] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
111 Chu DT, Nguyen TT, Tien NLB, Tran DK, Jeong JH, Anh PG, Thanh VV, Truong DT, Dinh TC. Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications. Cells 2020;9:E563. [PMID: 32121074 DOI: 10.3390/cells9030563] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
112 Holan V, Hermankova B, Krulova M, Zajicova A. Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy. World J Stem Cells 2019;11:957-67. [PMID: 31768222 DOI: 10.4252/wjsc.v11.i11.957] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
113 Jonsdottir-Buch SM, Sigurgrimsdottir H, Lieder R, Sigurjonsson OE. Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture. Cell Transplant 2015;24:1545-54. [PMID: 25198449 DOI: 10.3727/096368914X683043] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
114 Crisostomo V, Casado JG, Baez-diaz C, Blazquez R, Sanchez-margallo FM. Allogeneic cardiac stem cell administration for acute myocardial infarction. Expert Review of Cardiovascular Therapy 2015;13:285-99. [DOI: 10.1586/14779072.2015.1011621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
115 Viswanathan S, Keating A. Mesenchymal Stromal Cells: Latest Advances. In: Bernstein HS, editor. Tissue Engineering in Regenerative Medicine. Totowa: Humana Press; 2011. pp. 53-74. [DOI: 10.1007/978-1-61779-322-6_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Pawitan JA. Prospect of cell therapy for Parkinson's disease. Anat Cell Biol 2011;44:256-64. [PMID: 22254154 DOI: 10.5115/acb.2011.44.4.256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
117 Mishra PJ, Mishra PJ, Banerjee D. Keratinocyte Induced Differentiation of Mesenchymal Stem Cells into Dermal Myofibroblasts: A Role in Effective Wound Healing. Int J Transl Sci 2016;2016:5-32. [PMID: 27294075 DOI: 10.13052/ijts2246-8765.2016.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
118 Dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol. 2010;223:27-35. [PMID: 20020504 DOI: 10.1002/jcp.21987] [Cited by in Crossref: 49] [Cited by in F6Publishing: 102] [Article Influence: 4.5] [Reference Citation Analysis]
119 Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA. 2008;105:14638-14643. [PMID: 18794523 DOI: 10.1073/pnas.0803670105] [Cited by in Crossref: 292] [Cited by in F6Publishing: 283] [Article Influence: 22.5] [Reference Citation Analysis]
120 Kim Y, Baipaywad P, Jeong Y, Park H. Incorporation of gelatin microparticles on the formation of adipose-derived stem cell spheroids. International Journal of Biological Macromolecules 2018;110:472-8. [DOI: 10.1016/j.ijbiomac.2018.01.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
121 Lin W, Oh SK, Choo AB, George AJ. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. Cytotherapy. 2012;14:274-284. [PMID: 22136295 DOI: 10.3109/14653249.2011.635853] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
122 Baygan A, Aronsson-Kurttila W, Moretti G, Tibert B, Dahllöf G, Klingspor L, Gustafsson B, Khoein B, Moll G, Hausmann C, Svahn BM, Westgren M, Remberger M, Sadeghi B, Ringden O. Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis. Front Immunol 2017;8:795. [PMID: 28744284 DOI: 10.3389/fimmu.2017.00795] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
123 García-Sancho J, Sánchez A, Vega A, Noriega DC, Nocito M. Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease. Transplant Direct 2017;3:e205. [PMID: 28894792 DOI: 10.1097/TXD.0000000000000724] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
124 Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, Huan Y, Ge RC, Chen XW, Wang ZJ, Kim BJ, Hu X. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med. 2013;11:196. [PMID: 23978163 DOI: 10.1186/1479-5876-11-196] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
125 Akkoç T, Genç D. Asthma immunotherapy and treatment approaches with mesenchymal stem cells. Immunotherapy 2020;12:665-74. [PMID: 32489107 DOI: 10.2217/imt-2019-0194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Sadeghi B, Moretti G, Arnberg F, Samén E, Kohein B, Catar R, Kamhieh-Milz J, Geissler S, Moll G, Holmin S, Ringdén O. Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells. Front Immunol 2019;10:2685. [PMID: 31803191 DOI: 10.3389/fimmu.2019.02685] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
127 Abolhasani M, Rezaee MA, Mohammadi M, Ghadimi T, Mohammadi M, Rahmani MR. Immunomodulatory properties of umbilical cord vein mesenchymal stromal cells influenced by gestational age and in vitro expansion. Immunol Lett. 2018;194:62-68. [PMID: 29175314 DOI: 10.1016/j.imlet.2017.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
128 Zaher W, Harkness L, Jafari A, Kassem M. An update of human mesenchymal stem cell biology and their clinical uses. Arch Toxicol. 2014;88:1069-1082. [PMID: 24691703 DOI: 10.1007/s00204-014-1232-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
129 Janczewski AM, Wojtkiewicz J, Malinowska E, Doboszyńska A. Can Youthful Mesenchymal Stem Cells from Wharton's Jelly Bring a Breath of Fresh Air for COPD? Int J Mol Sci 2017;18:E2449. [PMID: 29156550 DOI: 10.3390/ijms18112449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
130 Hu C, Wu Z, Li L. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med 2020;24:40-9. [PMID: 31691463 DOI: 10.1111/jcmm.14788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
131 Zhang Y, Zhou S, Hu JM, Chen H, Liu D, Li M, Guo Y, Fan LP, Li LY, Liu YG, Zhao M. Preliminary Study of Bone Marrow-Derived Mesenchymal Stem Cells Pretreatment With Erythropoietin in Preventing Acute Rejection After Rat Renal Transplantation. Transplant Proc 2018;50:3873-80. [PMID: 30577280 DOI: 10.1016/j.transproceed.2018.04.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
132 Stimpfel M, Skutella T, Kubista M, Malicev E, Conrad S, Virant-Klun I. Potential stemness of frozen-thawed testicular biopsies without sperm in infertile men included into the in vitro fertilization programme. J Biomed Biotechnol 2012;2012:291038. [PMID: 22431916 DOI: 10.1155/2012/291038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
133 Ghivizzani SC, Gouze E, Gouze JN, Kay JD, Bush ML, Watson RS, Levings PP, Nickerson DM, Colahan PT, Robbins PD, Evans CH. Perspectives on the use of gene therapy for chronic joint diseases. Curr Gene Ther 2008;8:273-86. [PMID: 18691023 DOI: 10.2174/156652308785160638] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
134 Xie Y, Liu S, Wang L, Yang H, Tai C, Ling L, Chen L, Liu S, Wang B. Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis. Stem Cell Res Ther 2021;12:359. [PMID: 34158112 DOI: 10.1186/s13287-021-02430-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Kovacsovics-Bankowski M, Mauch K, Raber A, Streeter PR, Deans RJ, Maziarz RT, Van't Hof W. Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy 2008;10:730-42. [PMID: 18985479 DOI: 10.1080/14653240802320245] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
136 Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Subcutaneous Adipose Tissue-Derived Stem Cell Utility Is Independent of Anatomical Harvest Site. Biores Open Access 2015;4:131-45. [PMID: 26309790 DOI: 10.1089/biores.2014.0059] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
137 Beldi G, Khosravi M, Abdelgawad ME, Salomon BL, Uzan G, Haouas H, Naserian S. TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function. Stem Cell Res Ther 2020;11:281. [PMID: 32669116 DOI: 10.1186/s13287-020-01740-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
138 Lee SM, Lee SC, Kim SJ. Contribution of human adipose tissue-derived stem cells and the secretome to the skin allograft survival in mice. J Surg Res. 2014;188:280-289. [PMID: 24560349 DOI: 10.1016/j.jss.2013.10.063] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
139 Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial. Stem Cells Transl Med 2019;8:504-11. [PMID: 30835956 DOI: 10.1002/sctm.18-0122] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 39.5] [Reference Citation Analysis]
140 Chimutengwende-Gordon M, Donaldson J, Bentley G. Current solutions for the treatment of chronic articular cartilage defects in the knee. EFORT Open Rev 2020;5:156-63. [PMID: 32296549 DOI: 10.1302/2058-5241.5.190031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
141 Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood. 2009;113:6576-6583. [PMID: 19398717 DOI: 10.1182/blood-2009-02-203943] [Cited by in Crossref: 440] [Cited by in F6Publishing: 402] [Article Influence: 36.7] [Reference Citation Analysis]
142 Ho MH, Heydarkhan S, Vernet D, Kovanecz I, Ferrini MG, Bhatia NN, Gonzalez-Cadavid NF. Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol 2009;114:300-9. [PMID: 19622991 DOI: 10.1097/AOG.0b013e3181af6abd] [Cited by in Crossref: 42] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
143 Anzalone R, Iacono ML, Corrao S, Magno F, Loria T, Cappello F, Zummo G, Farina F, La Rocca G. New Emerging Potentials for Human Wharton’s Jelly Mesenchymal Stem Cells: Immunological Features and Hepatocyte-Like Differentiative Capacity. Stem Cells and Development 2010;19:423-38. [DOI: 10.1089/scd.2009.0299] [Cited by in Crossref: 140] [Cited by in F6Publishing: 119] [Article Influence: 12.7] [Reference Citation Analysis]
144 Schatton T, Frank MH. Antitumor immunity and cancer stem cells. Ann N Y Acad Sci 2009;1176:154-69. [PMID: 19796244 DOI: 10.1111/j.1749-6632.2009.04568.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 110] [Article Influence: 10.0] [Reference Citation Analysis]
145 Fathi-Kazerooni M, Tavoosidana G, Taghizadeh-Jahed M, Khanjani S, Golshahi H, Gargett CE, Edalatkhah H, Kazemnejad S. Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow stem cells in mice model. Cytotherapy. 2017;19:1474-1490. [PMID: 29107739 DOI: 10.1016/j.jcyt.2017.08.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
146 Alstrup T, Eijken M, Bohn AB, Møller B, Damsgaard TE. Isolation of Adipose Tissue-Derived Stem Cells: Enzymatic Digestion in Combination with Mechanical Distortion to Increase Adipose Tissue-Derived Stem Cell Yield from Human Aspirated Fat. Curr Protoc Stem Cell Biol 2019;48:e68. [PMID: 30365239 DOI: 10.1002/cpsc.68] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
147 Ranera B, Antczak D, Miller D, Doroshenkova T, Ryan A, Mcilwraith CW, Barry F. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes: Properties of allogeneic mesenchymal stem cells. Equine Vet J 2016;48:253-60. [DOI: 10.1111/evj.12414] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
148 Noriega DC, Ardura F, Hernández-ramajo R, Martín-ferrero MÁ, Sánchez-lite I, Toribio B, Alberca M, García V, Moraleda JM, Sánchez A, García-sancho J. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial. Transplantation 2017;101:1945-51. [DOI: 10.1097/tp.0000000000001484] [Cited by in Crossref: 88] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
149 Gaudet JM, Ribot EJ, Chen Y, Gilbert KM, Foster PJ. Tracking the fate of stem cell implants with fluorine-19 MRI. PLoS One 2015;10:e0118544. [PMID: 25767871 DOI: 10.1371/journal.pone.0118544] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
150 da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008;26:2287-2299. [PMID: 18566331 DOI: 10.1634/stemcells.2007-1122] [Cited by in Crossref: 737] [Cited by in F6Publishing: 628] [Article Influence: 56.7] [Reference Citation Analysis]
151 Brunswig-Spickenheier B, Boche J, Westenfelder C, Peimann F, Gruber AD, Jaquet K, Krause K, Zustin J, Zander AR, Lange C. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury. Stem Cells Dev 2010;19:719-29. [PMID: 20143956 DOI: 10.1089/scd.2009.0494] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
152 van Ramshorst J, Rodrigo SF, Schalij MJ, Beeres SL, Bax JJ, Atsma DE. Bone marrow cell injection for chronic myocardial ischemia: the past and the future. J Cardiovasc Transl Res 2011;4:182-91. [PMID: 21213093 DOI: 10.1007/s12265-010-9249-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
153 Hivelin M, Klimczak A, Cwykiel J, Sonmez E, Nasir S, Gatherwright J, Siemionow M. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model. Arch Immunol Ther Exp (Warsz) 2016;64:299-310. [PMID: 26708158 DOI: 10.1007/s00005-015-0380-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
154 Jackson WM, Alexander PG, Bulken-Hoover JD, Vogler JA, Ji Y, McKay P, Nesti LJ, Tuan RS. Mesenchymal progenitor cells derived from traumatized muscle enhance neurite growth. J Tissue Eng Regen Med 2013;7:443-51. [PMID: 22552971 DOI: 10.1002/term.539] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
155 Klaus M, Stavroulaki E, Kastrinaki M, Fragioudaki P, Giannikou K, Psyllaki M, Pontikoglou C, Tsoukatou D, Mamalaki C, Papadaki HA. Reserves, Functional, Immunoregulatory, and Cytogenetic Properties of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes. Stem Cells and Development 2010;19:1043-54. [DOI: 10.1089/scd.2009.0286] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
156 Longhini ALF, Salazar TE, Vieira C, Trinh T, Duan Y, Pay LM, Li Calzi S, Losh M, Johnston NA, Xie H, Kim M, Hunt RJ, Yoder MC, Santoro D, McCarrel TM, Grant MB. Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS One. 2019;14:e0212642. [PMID: 30870461 DOI: 10.1371/journal.pone.0212642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
157 Jang YO, Kim MY, Cho MY, Baik SK, Cho YZ, Kwon SO. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model. BMC Gastroenterol. 2014;14:198. [PMID: 25425284 DOI: 10.1186/s12876-014-0198-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
158 Bieback K, Hecker A, Schlechter T, Hofmann I, Brousos N, Redmer T, Besser D, Klüter H, Müller AM, Becker M. Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy 2012;14:570-83. [DOI: 10.3109/14653249.2011.652809] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
159 Bonfield TL, Nolan Koloze MT, Lennon DP, Caplan AI. Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond). 2010;7:51. [PMID: 20974000 DOI: 10.1186/1476-9255-7-51] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
160 Singh VK, Saini A, Chandra R. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies. Front Mol Biosci 2017;4:52. [PMID: 28785557 DOI: 10.3389/fmolb.2017.00052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
161 Mascarenhas S, Avalos B, Ardoin SP. An update on stem cell transplantation in autoimmune rheumatologic disorders. Curr Allergy Asthma Rep 2012;12:530-40. [PMID: 22956390 DOI: 10.1007/s11882-012-0298-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
162 Hall SR, Jiang Y, Leary E, Yavanian G, Eminli S, O'Neill DW, Marasco WA. Identification and isolation of small CD44-negative mesenchymal stem/progenitor cells from human bone marrow using elutriation and polychromatic flow cytometry. Stem Cells Transl Med 2013;2:567-78. [PMID: 23847000 DOI: 10.5966/sctm.2012-0155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
163 Xu L, Gong Y, Wang B, Shi K, Hou Y, Wang L, Lin Z, Han Y, Lu L, Chen D, Lin X, Zeng Q, Feng W, Chen Y. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. J Gastroenterol Hepatol. 2014;29:1620-1628. [PMID: 24942592 DOI: 10.1111/jgh.12653] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 9.5] [Reference Citation Analysis]
164 Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol. 2011;164:1-8. [PMID: 21352202 DOI: 10.1111/j.1365-2249] [Reference Citation Analysis]
165 Aldridge A, Kouroupis D, Churchman S, English A, Ingham E, Jones E. Assay validation for the assessment of adipogenesis of multipotential stromal cells--a direct comparison of four different methods. Cytotherapy 2013;15:89-101. [PMID: 23260089 DOI: 10.1016/j.jcyt.2012.07.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
166 Bukulmez H. Mesenchymal Stem Cell Treatment in Mice Models of Systemic Lupus Erythematosus. In: Malemud CJ, Alsberg E, editors. Mesenchymal Stem Cells and Immunomodulation. Cham: Springer International Publishing; 2016. pp. 25-42. [DOI: 10.1007/978-3-319-46733-7_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
167 Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, Mazhari R, Boyle AJ, Zambrano JP, Rodriguez JE, Dulce R, Pattany PM, Valdes D, Revilla C, Heldman AW, McNiece I, Hare JM. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010;107:913-22. [PMID: 20671238 DOI: 10.1161/CIRCRESAHA.110.222703] [Cited by in Crossref: 536] [Cited by in F6Publishing: 305] [Article Influence: 48.7] [Reference Citation Analysis]
168 Yun CW, Lee SH. Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease. Int J Mol Sci 2019;20:E982. [PMID: 30813471 DOI: 10.3390/ijms20040982] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
169 Dong H, Wang Z, Chen Y, Li Y. Protective Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Insulin Secretion and Inflammation in the Treatment of Severe Acute Pancreatitis in Rats. Transplant Proc 2020;52:333-44. [PMID: 31928780 DOI: 10.1016/j.transproceed.2019.10.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Wu XB, Tao R. Hepatocyte differentiation of mesenchymal stem cells. Hepatobiliary Pancreat Dis Int. 2012;11:360-371. [PMID: 22893462 DOI: 10.1016/s1499-3872(12)60193-3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
171 Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res 2012;13:3. [PMID: 22235752 DOI: 10.1186/1465-9921-13-3] [Cited by in Crossref: 111] [Cited by in F6Publishing: 94] [Article Influence: 12.3] [Reference Citation Analysis]
172 Masumoto H, Sakata R. Cardiovascular surgery for realization of regenerative medicine. Gen Thorac Cardiovasc Surg 2012;60:744-55. [PMID: 22933086 DOI: 10.1007/s11748-012-0139-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
173 Qi M, Zhang L, Ma Y, Shuai Y, Li L, Luo K, Liu W, Jin Y. Autophagy Maintains the Function of Bone Marrow Mesenchymal Stem Cells to Prevent Estrogen Deficiency-Induced Osteoporosis. Theranostics 2017;7:4498-516. [PMID: 29158841 DOI: 10.7150/thno.17949] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 15.0] [Reference Citation Analysis]
174 Pourrajab F, Forouzannia SK, Tabatabaee SA. Molecular characteristics of bone marrow mesenchymal stem cells, source of regenerative medicine. International Journal of Cardiology 2013;163:125-31. [DOI: 10.1016/j.ijcard.2011.11.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
175 Orlando G, Hematti P, Stratta RJ, Burke GW, Di Cocco P, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: Current status and future challenges. Ann Surg. 2010;252:915-928. [PMID: 21107102 DOI: 10.1097/sla.0b013e3181f3efb0] [Cited by in Crossref: 92] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
176 Jacobs SA, Pinxteren J, Roobrouck VD, Luyckx A, van't Hof W, Deans R, Verfaillie CM, Waer M, Billiau AD, Van Gool SW. Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses. Cell Transplant. 2013;22:1915-1928. [PMID: 23031260 DOI: 10.3727/096368912x657369] [Cited by in Crossref: 58] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
177 Hanson SE, Kleinbeck KR, Cantu D, Kim J, Bentz ML, Faucher LD, Kao WJ, Hematti P. Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. J Tissue Eng Regen Med 2016;10:E90-E100. [PMID: 23418160 DOI: 10.1002/term.1700] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
178 Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J Hepatol. 2009;50:1247-1257. [PMID: 19394103 DOI: 10.1016/j.jhep.2009.03.006] [Cited by in Crossref: 121] [Cited by in F6Publishing: 108] [Article Influence: 10.1] [Reference Citation Analysis]
179 Mesples A, Majeed N, Zhang Y, Hu X. Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results. Med Sci Monit 2013;19:852-7. [PMID: 24121994 DOI: 10.12659/MSM.889525] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
180 Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Exp Hematol 2008;36:1370-6. [PMID: 18619727 DOI: 10.1016/j.exphem.2008.04.022] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
181 Gómez-Aristizábal A, Keating A, Davies JE. Mesenchymal stromal cells as supportive cells for hepatocytes. Mol Ther 2009;17:1504-8. [PMID: 19584815 DOI: 10.1038/mt.2009.158] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
182 El-Serafi I, Remberger M, Ringdèn O, Törlén J, Sundin M, Björklund A, Winiarski J, Mattsson J. Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation. Clin Transl Sci 2020;13:293-300. [PMID: 31675173 DOI: 10.1111/cts.12709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Jung IH, Lee SH, Jun CM, Oh N, Yun JH. Characterization of the enhanced bone regenerative capacity of human periodontal ligament stem cells engineered to express the gene encoding bone morphogenetic protein 2. Tissue Eng Part A 2014;20:2189-99. [PMID: 24494708 DOI: 10.1089/ten.TEA.2013.0648] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
184 Habib HS, Halawa TF, Atta HM. Therapeutic applications of mesenchymal stroma cells in pediatric diseases: current aspects and future perspectives. Med Sci Monit. 2011;17:RA233-RA239. [PMID: 22037754 DOI: 10.12659/msm.882036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
185 Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:223. [PMID: 18947375 DOI: 10.1186/ar2514] [Cited by in Crossref: 191] [Cited by in F6Publishing: 170] [Article Influence: 14.7] [Reference Citation Analysis]
186 Andrews KL, Houdek MT, Kiemele LJ. Wound management of chronic diabetic foot ulcers: From the basics to regenerative medicine. Prosthetics & Orthotics International 2015;39:29-39. [DOI: 10.1177/0309364614534296] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
187 Carmelo JG, Fernandes-platzgummer A, Diogo MM, da Silva CL, Cabral JMS. A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue. Biotechnology Journal 2015;10:1235-47. [DOI: 10.1002/biot.201400586] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
188 Agata H, Sumita Y, Hidaka T, Iwatake M, Kagami H, Asahina I. Intra-Bone Marrow Administration of Mesenchymal Stem/Stromal Cells Is a Promising Approach for Treating Osteoporosis. Stem Cells Int 2019;2019:4214281. [PMID: 31781240 DOI: 10.1155/2019/4214281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
189 Rampino T, Gregorini M, Bedino G, Piotti G, Gabanti E, Ibatici A, Sessarego N, Piacenza C, Balenzano CT, Esposito P, Bosio F, Soccio G, Frassoni F, Dal Canton A. Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. Clin Sci (Lond) 2011;120:25-36. [PMID: 20583996 DOI: 10.1042/CS20100147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
190 Girdlestone J, Limbani VA, Cutler AJ, Navarrete CV. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy 2009;11:738-48. [PMID: 19878060 DOI: 10.3109/14653240903079401] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
191 Le Thi Bich P, Nguyen Thi H, Dang Ngo Chau H, Phan Van T, Do Q, Dong Khac H, Le Van D, Nguyen Huy L, Mai Cong K, Ta Ba T, Do Minh T, Vu Bich N, Truong Chau N, Van Pham P. Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study. Stem Cell Res Ther. 2020;11:60. [PMID: 32054512 DOI: 10.1186/s13287-020-1583-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
192 Li R, Liang J, He Y, Qin J, He H, Lee S, Pang Z, Wang J. Sustained Release of Immunosuppressant by Nanoparticle-anchoring Hydrogel Scaffold Improved the Survival of Transplanted Stem Cells and Tissue Regeneration. Theranostics 2018;8:878-93. [PMID: 29463988 DOI: 10.7150/thno.22072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
193 Shin MS. Present and future of aesthetic plastic surgery in Korea. J Korean Med Assoc 2011;54:581. [DOI: 10.5124/jkma.2011.54.6.581] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
194 Jia Z, Jiao C, Zhao S, Li X, Ren X, Zhang L, Han ZC, Zhang X. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Exp Eye Res. 2012;102:44-49. [PMID: 22800963 DOI: 10.1016/j.exer.2012.06.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
195 Stroncek DF, Jin P, Wang E, Ren J, Sabatino M, Marincola FM. Global transcriptional analysis for biomarker discovery and validation in cellular therapies. Mol Diagn Ther 2009;13:181-93. [PMID: 19650671 DOI: 10.2165/01250444-200913030-00003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
196 Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cooke KR. Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. Stem Cells 2015;33:601-14. [PMID: 25336340 DOI: 10.1002/stem.1867] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
197 Holan V, Palacka K, Hermankova B. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials. Cells 2021;10:588. [PMID: 33799995 DOI: 10.3390/cells10030588] [Reference Citation Analysis]
198 Auletta JJ, Cooke KR, Solchaga LA, Deans RJ, van't Hof W. Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant 2010;16:891-906. [PMID: 20018250 DOI: 10.1016/j.bbmt.2009.12.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
199 Tomchuck SL, Henkle SL, Coffelt SB, Betancourt AM. Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. PLoS One 2012;7:e39592. [PMID: 22745793 DOI: 10.1371/journal.pone.0039592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
200 Vellasamy S, Sandrasaigaran P, Vidyadaran S, Abdullah M, George E, Ramasamy R. Mesenchymal stem cells of human placenta and umbilical cord suppress T-cell proliferation at G 0 phase of cell cycle: Fetus origin mesenchymal stem cells suppress T cells. Cell Biol Int 2013;37:250-6. [DOI: 10.1002/cbin.10033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
201 Dryden GW. Overview of biologic therapy for Crohn’s disease. Expert Opin Biol Ther. 2009;9:967-974. [PMID: 19591627 DOI: 10.1517/14712590902956615] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
202 Lin H, Ramesh S, Chang Y, Tsai C, Tsai C, Shibu MA, Tamilselvi S, Mahalakshmi B, Kuo W, Huang C. D‐galactose‐induced toxicity associated senescence mitigated by alpinate oxyphyllae fructus fortified adipose‐derived mesenchymal stem cells. Environmental Toxicology 2021;36:86-94. [DOI: 10.1002/tox.23014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Pulavendran S, Rose C, Mandal AB. Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice. J Nanobiotechnology. 2011;9:15. [PMID: 21526984 DOI: 10.1186/1477-3155-9-15] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
204 Auletta JJ, Bartholomew AM, Maziarz RT, Deans RJ, Miller RH, Lazarus HM, Cohen JA. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy. 2012;4:529-547. [PMID: 22642335 DOI: 10.2217/imt.12.41] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
205 Mitsiadis TA, Woloszyk A, Jiménez-rojo L. Nanodentistry: combining nanostructured materials and stem cells for dental tissue regeneration. Nanomedicine 2012;7:1743-53. [DOI: 10.2217/nnm.12.146] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
206 Jung S, Panchalingam KM, Rosenberg L, Behie LA. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int 2012;2012:123030. [PMID: 22645619 DOI: 10.1155/2012/123030] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 11.3] [Reference Citation Analysis]
207 Abou Nader Z, Espéli M, Balabanian K, P Lemos J. Culture, Expansion and Differentiation of Mouse Bone-Derived Mesenchymal Stromal Cells. Methods Mol Biol 2021;2308:35-46. [PMID: 34057712 DOI: 10.1007/978-1-0716-1425-9_3] [Reference Citation Analysis]
208 Hanson S, Thibeault SL, Hematti P. Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction. Curr Stem Cell Res Ther 2010;5:268-72. [PMID: 19951250 DOI: 10.2174/157488810791824449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
209 Hermankova B, Zajicova A, Javorkova E, Chudickova M, Trosan P, Hajkova M, Krulova M, Holan V. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells. Immunobiology 2016;221:129-36. [DOI: 10.1016/j.imbio.2015.09.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
210 Renner P, Eggenhofer E, Rosenauer A, Popp FC, Steinmann JF, Slowik P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function. Transplant Proc. 2009;41:2607-2611. [PMID: 19715984 DOI: 10.1016/j.transproceed.2009.06.119] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
211 Puglisi MA, Tesori V, Lattanzi W, Piscaglia AC, Gasbarrini GB, D'Ugo DM, Gasbarrini A. Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol. 2011;2011:860578. [PMID: 22228987 DOI: 10.1155/2011/] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
212 Atoui R, Chiu RC. Concise review: immunomodulatory properties of mesenchymal stem cells in cellular transplantation: update, controversies, and unknowns.Stem Cells Transl Med. 2012;1:200-205. [PMID: 23197779 DOI: 10.5966/sctm.2011-0012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
213 Braza F, Dirou S, Forest V, Sauzeau V, Hassoun D, Chesné J, Cheminant-Muller MA, Sagan C, Magnan A, Lemarchand P. Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma. Stem Cells 2016;34:1836-45. [PMID: 26891455 DOI: 10.1002/stem.2344] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 15.8] [Reference Citation Analysis]
214 Tögel FE, Westenfelder C. Treatment of Acute Kidney Injury with Allogeneic Mesenchymal Stem Cells: Preclinical and Initial Clinical Data. Regenerative Nephrology. Elsevier; 2011. pp. 315-39. [DOI: 10.1016/b978-0-12-380928-5.10021-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Bartunek J, Behfar A, Vanderheyden M, Wijns W, Terzic A. Mesenchymal stem cells and cardiac repair: principles and practice. J Cardiovasc Transl Res 2008;1:115-9. [PMID: 20559905 DOI: 10.1007/s12265-008-9021-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
216 Sicari BM, Dearth CL, Badylak SF. Tissue Engineering and Regenerative Medicine Approaches to Enhance the Functional Response to Skeletal Muscle Injury: Tissue Engineering and Regenerative Medicine Approaches to Skeletal Muscle Injury. Anat Rec 2014;297:51-64. [DOI: 10.1002/ar.22794] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
217 Aldahmash A, Haack-sørensen M, Al-nbaheen M, Harkness L, Abdallah BM, Kassem M. Human Serum is as Efficient as Fetal Bovine Serum in Supporting Proliferation and Differentiation of Human Multipotent Stromal (Mesenchymal) Stem Cells In Vitro and In Vivo. Stem Cell Rev and Rep 2011;7:860-8. [DOI: 10.1007/s12015-011-9274-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
218 Auletta JJ, Deans RJ, Bartholomew AM. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood. 2012;119:1801-1809. [PMID: 22228625 DOI: 10.1182/blood-2011-10-384354] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
219 Bidarra SJ, Barrias CC, Granja PL. Injectable alginate hydrogels for cell delivery in tissue engineering. Acta Biomaterialia 2014;10:1646-62. [DOI: 10.1016/j.actbio.2013.12.006] [Cited by in Crossref: 276] [Cited by in F6Publishing: 219] [Article Influence: 39.4] [Reference Citation Analysis]
220 Hosseinpur Z, Hashemi SM, Salehi E, Ghazanfari T. Comparison of TGF-β1 and NO production by mesenchymal stem cells isolated from murine lung and adipose tissues. Immunopharmacol Immunotoxicol 2016;38:214-20. [PMID: 27097976 DOI: 10.3109/08923973.2016.1168434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
221 Li F, Chen YZ, Miao ZN, Zheng SY, Jin J. Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects. Cell Reprogram. 2012;14:334-341. [PMID: 22816556 DOI: 10.1089/cell.2012.0002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
222 Wise AF, Ricardo SD. Mesenchymal stem cells in kidney inflammation and repair. Nephrology (Carlton). 2012;17:1-10. [PMID: 21777348 DOI: 10.1111/j.1440-1797.2011.01501.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
223 Li R, Zhang Y, Zheng X, Peng S, Yuan K, Zhang X, Min W. Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC. Sci Rep 2017;7:43188. [PMID: 28230210 DOI: 10.1038/srep43188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
224 Ma MT, Leung KK, Tsang KS, Leung PS. Reduced immunogenicity of pancreatic progenitor cells derived from first-trimester human fetal pancreas. The International Journal of Biochemistry & Cell Biology 2011;43:812-20. [DOI: 10.1016/j.biocel.2011.02.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
225 Christ B, Brückner S. Rodent animal models for surrogate analysis of cell therapy in acute liver failure. Front Physiol. 2012;3:78. [PMID: 22485094 DOI: 10.3389/fphys.2012.00078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
226 Idziak M, Pędzisz P, Burdzińska A, Gala K, Pączek L. Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro. Exp Toxicol Pathol 2014;66:187-94. [PMID: 24548687 DOI: 10.1016/j.etp.2014.01.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
227 Panchalingam KM, Jung S, Rosenberg L, Behie LA. Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review. Stem Cell Res Ther 2015;6:225. [PMID: 26597928 DOI: 10.1186/s13287-015-0228-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 12.5] [Reference Citation Analysis]
228 Dave S. Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes. Adv Biomed Res 2014;3:266. [PMID: 25625105 DOI: 10.4103/2277-9175.148247] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
229 Fändrich F. Tolerance in clinical transplantation: progress, challenge or just a dream? Langenbecks Arch Surg 2011;396:475-87. [DOI: 10.1007/s00423-011-0757-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
230 Svobodova E, Krulova M, Zajicova A, Pokorna K, Prochazkova J, Trosan P, Holan V. The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. Stem Cells Dev. 2012;21:901-910. [PMID: 21663543 DOI: 10.1089/scd.2011.0157] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 7.4] [Reference Citation Analysis]
231 Introna M, Rambaldi A. Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease: successes and hurdles. Curr Opin Organ Transplant 2015;20:72-8. [PMID: 25563994 DOI: 10.1097/MOT.0000000000000158] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
232 Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, Agarwal A, Curtis LM. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am J Physiol Renal Physiol 2011;300:F254-62. [PMID: 21048024 DOI: 10.1152/ajprenal.00594.2010] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 7.4] [Reference Citation Analysis]
233 Pei M, He F, Boyce B, Kish V. Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs. Osteoarthritis and Cartilage 2009;17:714-22. [DOI: 10.1016/j.joca.2008.11.017] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 8.8] [Reference Citation Analysis]
234 Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008;45:523-529. [PMID: 18835562 DOI: 10.1016/j.yjmcc.2008.09.122] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
235 Pombero A, Garcia-Lopez R, Martinez S. Brain mesenchymal stem cells: physiology and pathological implications. Dev Growth Differ 2016;58:469-80. [PMID: 27273235 DOI: 10.1111/dgd.12296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
236 Auletta JJ, Cooke KR. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 2009;21:30-8. [PMID: 19242239 DOI: 10.1097/MOP.0b013e3283207b2f] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
237 Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE. Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One. 2013;8:e68984. [PMID: 23874839 DOI: 10.1371/journal.pone.0068984] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 7.5] [Reference Citation Analysis]
238 Jones CP, Rankin SM. Bone marrow-derived stem cells and respiratory disease. Chest 2011;140:205-11. [PMID: 21729891 DOI: 10.1378/chest.10-2348] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
239 Jin J, Wang J, Huang J, Huang F, Fu J, Yang X, Miao Z. Transplantation of human placenta-derived mesenchymal stem cells in a silk fibroin/hydroxyapatite scaffold improves bone repair in rabbits. J Biosci Bioeng. 2014;118:593-598. [PMID: 24894683 DOI: 10.1016/j.jbiosc.2014.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
240 Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, Sayegh MH, Abdi R. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 2009;183:993-1004. [PMID: 19561093 DOI: 10.4049/jimmunol.0900803] [Cited by in Crossref: 272] [Cited by in F6Publishing: 237] [Article Influence: 22.7] [Reference Citation Analysis]
241 Stroncek DF, Jin P, Wang E, Ren J, Sabatino M, Marincola FM. Global Transcriptional Analysis for Biomarker Discovery and Validation in Cellular Therapies. Mol Diag Ther 2009;13:181-93. [DOI: 10.1007/bf03256324] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
242 Raynaud CM, Rafii A. The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting. Stem Cells Int 2013;2013:892340. [PMID: 23864866 DOI: 10.1155/2013/892340] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
243 Jung S, Panchalingam KM, Wuerth RD, Rosenberg L, Behie LA. Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol Appl Biochem 2012;59:106-20. [PMID: 23586791 DOI: 10.1002/bab.1006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 8.8] [Reference Citation Analysis]
244 Lu G, Zhu S, Ke Y, Jiang X, Zhang S. Transplantation-potential-related biological properties of decidua basalis mesenchymal stem cells from maternal human term placenta. Cell Tissue Res 2013;352:301-12. [PMID: 23397423 DOI: 10.1007/s00441-013-1560-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
245 Joshi L, Chelluri LK, Gaddam S. Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review. Arch Immunol Ther Exp 2015;63:427-33. [DOI: 10.1007/s00005-015-0347-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
246 Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010;9:129. [PMID: 20509882 DOI: 10.1186/1476-4598-9-129] [Cited by in Crossref: 140] [Cited by in F6Publishing: 118] [Article Influence: 12.7] [Reference Citation Analysis]
247 Sinden JD, Vishnubhatla I, Muir KW. Prospects for stem cell-derived therapy in stroke. Prog Brain Res 2012;201:119-67. [PMID: 23186713 DOI: 10.1016/B978-0-444-59544-7.00007-X] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
248 Qiao H, Zhang R, Gao L, Guo Y, Wang J, Li X, Li C, Chen Y, Cao F. Molecular Imaging for Comparison of Different Growth Factors on Bone Marrow-Derived Mesenchymal Stromal Cells' Survival and Proliferation In Vivo.Biomed Res Int. 2016;2016:1363902. [PMID: 27419126 DOI: 10.1155/2016/1363902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
249 Kariminekoo S, Movassaghpour A, Rahimzadeh A, Talebi M, Shamsasenjan K, Akbarzadeh A. Implications of mesenchymal stem cells in regenerative medicine. Artif Cells Nanomed Biotechnol. 2016;44:749-757. [PMID: 26757594 DOI: 10.3109/21691401.2015.1129620] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 10.2] [Reference Citation Analysis]
250 Stamm C, Klose K, Choi YH. Clinical application of stem cells in the cardiovascular system. Adv Biochem Eng Biotechnol 2010;123:293-317. [PMID: 20803146 DOI: 10.1007/10_2010_77] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
251 Savelli S, Trombi L, D'Alessandro D, Moscato S, Pacini S, Giannotti S, Lapi S, Scatena F, Petrini M. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results. Cytotherapy 2018;20:556-63. [PMID: 29429942 DOI: 10.1016/j.jcyt.2017.12.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
252 Koppula PR, Chelluri LK, Polisetti N, Vemuganti GK. Histocompatibility testing of cultivated human bone marrow stromal cells - a promising step towards pre-clinical screening for allogeneic stem cell therapy. Cell Immunol 2009;259:61-5. [PMID: 19577229 DOI: 10.1016/j.cellimm.2009.05.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
253 Dentelli P, Barale C, Togliatto G, Trombetta A, Olgasi C, Gili M, Riganti C, Toppino M, Brizzi MF. A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells. Diabetologia. 2013;56:173-184. [PMID: 23064289 DOI: 10.1007/s00125-012-2734-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
254 Mannucci S, Calderan L, Quaranta P, Antonini S, Mosca F, Longoni B, Marzola P, Boschi F. Quantum dots labelling allows detection of the homing of mesenchymal stem cells administered as immunomodulatory therapy in an experimental model of pancreatic islets transplantation. J Anat 2017;230:381-8. [PMID: 27861845 DOI: 10.1111/joa.12563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
255 Cooke ME, Allon AA, Cheng T, Kuo AC, Kim HT, Vail TP, Marcucio RS, Schneider RA, Lotz JC, Alliston T. Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis Cartilage 2011;19:1210-8. [PMID: 21816228 DOI: 10.1016/j.joca.2011.07.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 8.3] [Reference Citation Analysis]
256 Svistushkin MV, Kotova SL, Shekhter AB, Svistushkin VM, Akovantseva AA, Frolova AA, Fayzullin AL, Starostina SV, Bezrukov EA, Sukhanov RB, Timashev SF, Butnaru DV, Timashev PS. Collagen fibrillar structures in vocal fold scarring and repair using stem cell therapy: a detailed histological, immunohistochemical and atomic force microscopy study. J Microsc 2019;274:55-68. [PMID: 30740689 DOI: 10.1111/jmi.12784] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
257 Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 2014;22:313-325. [PMID: 24844331 DOI: 10.1111/wrr.12173] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 27.8] [Reference Citation Analysis]
258 Wang L, Yu Y, Guan H, Qiao C. Effect of Human Umbilical Cord Mesenchymal Stem Cell Transplantation in a Rat Model of Preeclampsia. Reprod Sci 2016;23:1058-70. [DOI: 10.1177/1933719116630417] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
259 Bianco P. Back to the future: moving beyond "mesenchymal stem cells". J Cell Biochem 2011;112:1713-21. [PMID: 21416499 DOI: 10.1002/jcb.23103] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
260 Atoui R, Shum-Tim D, Chiu RC. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells". Ann Thorac Surg 2008;86:327-34. [PMID: 18573459 DOI: 10.1016/j.athoracsur.2008.03.038] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
261 Patel SA, Rameshwar P. Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells. Curr Pharmacogenomics Person Med 2011;9:229-39. [PMID: 21892378 DOI: 10.2174/187569211796957548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
262 Ahn H, Lee SY, Jung W, Pi J, Lee K. Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report. WJCC 2021;9:6798-803. [DOI: 10.12998/wjcc.v9.i23.6798] [Reference Citation Analysis]
263 Singh SP, Singh R, Gupta OP, Gupta S, Brahma Bhatt ML. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells. J Oncol 2020;2020:3963561. [PMID: 32211043 DOI: 10.1155/2020/3963561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
264 Gorbunov NV, Garrison BR, McDaniel DP, Zhai M, Liao PJ, Nurmemet D, Kiang JG. Adaptive redox response of mesenchymal stromal cells to stimulation with lipopolysaccharide inflammagen: mechanisms of remodeling of tissue barriers in sepsis. Oxid Med Cell Longev 2013;2013:186795. [PMID: 23710283 DOI: 10.1155/2013/186795] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
265 Hickson LJ, Eirin A, Lerman LO. Challenges and opportunities for stem cell therapy in patients with chronic kidney disease. Kidney Int 2016;89:767-78. [PMID: 26924058 DOI: 10.1016/j.kint.2015.11.023] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
266 Ozen I, Boix J, Paul G. Perivascular mesenchymal stem cells in the adult human brain: a future target for neuroregeneration? Clin Transl Med. 2012;1:30. [PMID: 23369339 DOI: 10.1186/2001-1326-1-30] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
267 Laflaquière B, Leclercq G, Choey C, Chen J, Peres S, Ito C, Jolicoeur M. Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect. Metabolites 2018;8:E18. [PMID: 29495309 DOI: 10.3390/metabo8010018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
268 Bieback K. Basic Biology of Mesenchymal Stem Cells. Transfus Med Hemother 2008;35:151-2. [PMID: 21547112 DOI: 10.1159/000132165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
269 Yiou R, Mahrouf-yorgov M, Trébeau C, Zanaty M, Lecointe C, Souktani R, Zadigue P, Figeac F, Rodriguez A. Delivery of human mesenchymal adipose-derived stem cells restores multiple urological dysfunctions in a rat model mimicking radical prostatectomy damages through tissue-specific paracrine mechanisms: Stem Cell Therapy of Radical Prostatectomy Sequels. Stem Cells 2016;34:392-404. [DOI: 10.1002/stem.2226] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
270 Remberger M, Ringdén O. Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients. Int J Hematol 2012;96:822-4. [PMID: 23143687 DOI: 10.1007/s12185-012-1218-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
271 Fleifel D, Rahmoon MA, AlOkda A, Nasr M, Elserafy M, El-Khamisy SF. Recent advances in stem cells therapy: A focus on cancer, Parkinson's and Alzheimer's. J Genet Eng Biotechnol 2018;16:427-32. [PMID: 30733756 DOI: 10.1016/j.jgeb.2018.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
272 Ting AE, Sherman W. Allogeneic stem cell transplantation for ischemic myocardial dysfunction: . Current Opinion in Organ Transplantation 2012;17:675-80. [DOI: 10.1097/mot.0b013e32835a66a1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
273 Vega A, Martín-Ferrero MA, Del Canto F, Alberca M, García V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015;99:1681-1690. [PMID: 25822648 DOI: 10.1097/tp.0000000000000678] [Cited by in Crossref: 322] [Cited by in F6Publishing: 153] [Article Influence: 53.7] [Reference Citation Analysis]
274 Li T, Liu ZL, Xiao M, Yang ZZ, Peng MZ, Li CD, Zhou XJ, Wang JW. Impact of bone marrow mesenchymal stem cell immunomodulation on the osteogenic effects of laponite. Stem Cell Res Ther 2018;9:100. [PMID: 29642953 DOI: 10.1186/s13287-018-0818-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
275 Passipieri JA, Kasai-Brunswick TH, Suhett G, Martins AB, Brasil GV, Campos DB, Rocha NN, Ramos IP, Mello DB, Rodrigues DC, Christie BB, Silva-Mendes BJ, Balduíno A, Sá RM, Lopes LM, Goldenberg RC, Campos de Carvalho AC, Carvalho AB. Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway. Stem Cell Res Ther 2014;5:102. [PMID: 25145631 DOI: 10.1186/scrt490] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
276 Brown BN, Sicari BM, Badylak SF. Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol 2014;5:510. [PMID: 25408693 DOI: 10.3389/fimmu.2014.00510] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 12.4] [Reference Citation Analysis]
277 Akkoc T. Mesenchymal Stem Cells in Asthma. Adv Exp Med Biol 2020;1247:101-8. [PMID: 31802444 DOI: 10.1007/5584_2019_460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Moraes L, Vasconcelos-dos-santos A, Santana FC, Godoy MA, Rosado-de-castro PH, Jasmin, Azevedo-pereira RL, Cintra WM, Gasparetto EL, Santiago MF, Mendez-otero R. Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease. Stem Cell Research 2012;9:143-55. [DOI: 10.1016/j.scr.2012.05.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
279 Kurtzberg J, Abdel-Azim H, Carpenter P, Chaudhury S, Horn B, Mahadeo K, Nemecek E, Neudorf S, Prasad V, Prockop S, Quigg T, Satwani P, Cheng A, Burke E, Hayes J, Skerrett D;  MSB-GVHD001/002 Study Group. A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2020;26:845-854. [PMID: 32018062 DOI: 10.1016/j.bbmt.2020.01.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 38.0] [Reference Citation Analysis]
280 Deans R, Babiss LE. Indication Transformation Maps and The Challenge of Live Cell Delivery. In: Vertès AA, Qureshi N, Caplan AI, Babiss LE, editors. Stem Cells in Regenerative Medicine. Chichester: John Wiley & Sons, Ltd; 2015. pp. 375-86. [DOI: 10.1002/9781118846193.ch20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
281 Dimarino AM, Caplan AI, Bonfield TL. Mesenchymal stem cells in tissue repair. Front Immunol. 2013;4:201. [PMID: 24027567 DOI: 10.3389/fimmu.2013.00201] [Cited by in Crossref: 244] [Cited by in F6Publishing: 217] [Article Influence: 30.5] [Reference Citation Analysis]
282 Chen YR, Yan X, Yuan FZ, Ye J, Xu BB, Zhou ZX, Mao ZM, Guan J, Song YF, Sun ZW, Wang XJ, Chen ZY, Wang DY, Fan BS, Yang M, Song ST, Jiang D, Yu JK. The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration In Vivo: A Review. Front Pharmacol. 2020;11:404. [PMID: 32308625 DOI: 10.3389/fphar.2020.00404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
283 Rodrigo SF, van Ramshorst J, Hoogslag GE, Boden H, Velders MA, Cannegieter SC, Roelofs H, Al Younis I, Dibbets-Schneider P, Fibbe WE. Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res. 2013;6:816-825. [PMID: 23982478 DOI: 10.1007/s12265-013-9507-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
284 Atoui R, Chiu RC. Immune responses after mesenchymal stem cell implantation. Methods Mol Biol 2013;1036:107-20. [PMID: 23807791 DOI: 10.1007/978-1-62703-511-8_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
285 von Bonin M, Stölzel F, Goedecke A, Richter K, Wuschek N, Hölig K, Platzbecker U, Illmer T, Schaich M, Schetelig J. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009;43:245-251. [PMID: 18820709 DOI: 10.1038/bmt.2008.316] [Cited by in Crossref: 223] [Cited by in F6Publishing: 206] [Article Influence: 17.2] [Reference Citation Analysis]
286 Reinders ME, Rabelink TJ. Adipose tissue-derived stem cells: can impure cell preparations give pure results? Nephrol Dial Transplant 2010;25:3805-7. [PMID: 20966189 DOI: 10.1093/ndt/gfq651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
287 Lavini-Ramos C, Silva HM, Soares-Schanoski A, Monteiro SM, Ferreira LRP, Pacanaro AP, Gomes S, Batista J, Faé K, Kalil J, Coelho V. MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells. Sci Rep 2017;7:874. [PMID: 28408751 DOI: 10.1038/s41598-017-00923-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
288 Denu RA, Hematti P. Effects of Oxidative Stress on Mesenchymal Stem Cell Biology. Oxid Med Cell Longev. 2016;2016:2989076. [PMID: 27413419 DOI: 10.1155/2016/2989076] [Cited by in Crossref: 133] [Cited by in F6Publishing: 126] [Article Influence: 26.6] [Reference Citation Analysis]
289 Kollar K, Seifried E, Henschler R. Therapeutic potential of intravenously administered human mesenchymal stromal cells. Hamostaseologie 2011;31:269-74. [PMID: 22064918 DOI: 10.5482/ha-1158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
290 Vernikouskaya I, Fekete N, Bannwarth M, Erle A, Rojewski M, Landfester K, Schmidtke-Schrezenmeier G, Schrezenmeier H, Rasche V. Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI. Contrast Media Mol Imaging 2014;9:109-21. [PMID: 24523056 DOI: 10.1002/cmmi.1544] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
291 Liao J, Chang C, Wu H, Lu Q. Cell-based therapies for systemic lupus erythematosus. Autoimmun Rev 2015;14:43-8. [PMID: 25308529 DOI: 10.1016/j.autrev.2014.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
292 de Lima KA, de Oliveira GL, Yaochite JN, Pinheiro DG, de Azevedo JT, Silva WA Jr, Covas DT, Couri CE, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KC. Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients. Stem Cell Res Ther 2016;7:92. [PMID: 27406064 DOI: 10.1186/s13287-016-0351-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
293 Kozanoglu I, Maytalman E. Isolation and Identification of Mesenchymal Stem Cells. In: Turksen K, editor. Adult and Embryonic Stem Cells. Totowa: Humana Press; 2012. pp. 25-32. [DOI: 10.1007/978-1-61779-630-2_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
294 Acquistapace A, Bru T, Lesault PF, Figeac F, Coudert AE, le Coz O, Christov C, Baudin X, Auber F, Yiou R, Dubois-Randé JL, Rodriguez AM. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells 2011;29:812-24. [PMID: 21433223 DOI: 10.1002/stem.632] [Cited by in Crossref: 146] [Cited by in F6Publishing: 129] [Article Influence: 14.6] [Reference Citation Analysis]
295 Kuraitis D, Giordano C, Ruel M, Musarò A, Suuronen EJ. Exploiting extracellular matrix-stem cell interactions: A review of natural materials for therapeutic muscle regeneration. Biomaterials 2012;33:428-43. [DOI: 10.1016/j.biomaterials.2011.09.078] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
296 Magnusson M, Sierra MI, Sasidharan R, Prashad SL, Romero M, Saarikoski P, Van Handel B, Huang A, Li X, Mikkola HK. Expansion on stromal cells preserves the undifferentiated state of human hematopoietic stem cells despite compromised reconstitution ability. PLoS One 2013;8:e53912. [PMID: 23342037 DOI: 10.1371/journal.pone.0053912] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
297 Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010;299:L760-70. [PMID: 20817776 DOI: 10.1152/ajplung.00182.2009] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 11.3] [Reference Citation Analysis]
298 Fukada S, Ma Y, Uezumi A. Adult stem cell and mesenchymal progenitor theories of aging. Front Cell Dev Biol. 2014;2:10. [PMID: 25364718 DOI: 10.3389/fcell.2014.00010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
299 Nejad-Moghaddam A, Tahmasbpour E, Sohrabiyan M, Jafari H, Ghanei M. Stem cells therapy: a review on approaches that can be used for treatment of respiratory failures in sulfur mustard-injured patients. Immunopharmacol Immunotoxicol 2018;40:359-67. [PMID: 30488735 DOI: 10.1080/08923973.2018.1510961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
300 Yuan L, Xiao ZT, Huang XZ, Wu MJ, Shi H, Liu AF. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation. Ren Fail 2016;38:1432-40. [PMID: 27416851 DOI: 10.3109/0886022X.2015.1136894] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
301 Han KH, Ro H, Hong JH, Lee EM, Cho B, Yeom HJ, Kim MG, Oh KH, Ahn C, Yang J. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Transpl Immunol 2011;25:7-15. [PMID: 21635949 DOI: 10.1016/j.trim.2011.05.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
302 Luz-Crawford P, Jorgensen C, Djouad F. Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages. Results Probl Cell Differ 2017;62:61-72. [PMID: 28455706 DOI: 10.1007/978-3-319-54090-0_4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
303 Karlsson H, Erkers T, Nava S, Ruhm S, Westgren M, Ringdén O. Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro. Clin Exp Immunol. 2012;167:543-555. [PMID: 22288598 DOI: 10.1111/j.1365-2249.2011.04540.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
304 Işık S, Karaman M, Adan A, Kıray M, Bağrıyanık HA, Sözmen ŞÇ, Kozanoğlu İ, Karaman Ö, Baran Y, Uzuner N. Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model. Eur Arch Otorhinolaryngol 2017;274:197-207. [PMID: 27380271 DOI: 10.1007/s00405-016-4166-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
305 Orlando G, Hematti P, Stratta RJ, Burke GW, Di Cocco P, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg. 2010;252:915-928. [PMID: 21107102 DOI: 10.1097/sla. 0b013e3181f3efb0] [Reference Citation Analysis]
306 Muraca M, Piccoli M, Franzin C, Tolomeo AM, Jurga M, Pozzobon M, Perilongo G. Diverging Concepts and Novel Perspectives in Regenerative Medicine. Int J Mol Sci 2017;18:E1021. [PMID: 28486410 DOI: 10.3390/ijms18051021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
307 Ichim TE, Solano F, Lara F, Rodriguez JP, Cristea O, Minev B, Ramos F, Woods EJ, Murphy MP, Alexandrescu DT, Patel AN, Riordan NH. Combination stem cell therapy for heart failure. Int Arch Med 2010;3:5. [PMID: 20398245 DOI: 10.1186/1755-7682-3-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
308 Leite MT, Freitas-Filho LG, Oliveira AS, Semedo-Kuriki P, Laks M, Arias VE, Peixoto PS. The use of mesenchymal stem cells in bladder augmentation. Pediatr Surg Int 2014;30:361-70. [PMID: 24500280 DOI: 10.1007/s00383-014-3465-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
309 Qiu X, Lin H, Wang Y, Yu W, Chen Y, Wang R, Dai Y. Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocin-induced diabetic rats. J Sex Med. 2011;8:427-436. [PMID: 21091881 DOI: 10.1111/j.1743-6109.2010.02118.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
310 Hanson SE, Gutowski KA, Hematti P. Clinical applications of mesenchymal stem cells in soft tissue augmentation. Aesthet Surg J. 2010;30:838-842. [PMID: 21131458 DOI: 10.1177/1090820X10386364] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
311 Casteilla L, Planat-Benard V, Bourin P, Laharrague P, Cousin B. [Use of adipose tissue in regenerative medicine]. Transfus Clin Biol 2011;18:124-8. [PMID: 21397545 DOI: 10.1016/j.tracli.2011.01.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
312 Sundin M, D'arcy P, Johansson CC, Barrett AJ, Lönnies H, Sundberg B, Nava S, Kiessling R, Mougiakakos D, Le Blanc K. Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? J Immunother 2011;34:336-42. [PMID: 21499129 DOI: 10.1097/CJI.0b013e318217007c] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
313 Alipour R, Masoumi Karimi M, Hashemi-Beni B, Adib M, Sereshki N, Sadeghi F. Indoleamine 2,3-Dioxygenase Is Dispensable for The Immunomodulatory Function of Stem Cells from Human Exfoliated Deciduous Teeth. Cell J 2017;18:597-608. [PMID: 28042544 DOI: 10.22074/cellj.2016.4726] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
314 Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 2010;19:693-706. [PMID: 20067407 DOI: 10.1089/scd.2009.0365] [Cited by in Crossref: 105] [Cited by in F6Publishing: 106] [Article Influence: 9.5] [Reference Citation Analysis]
315 Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg. 2010;125:510-516. [PMID: 20124836 DOI: 10.1097/prs.0b013e3181c722bb] [Cited by in Crossref: 101] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
316 Domínguez-Bendala J, Inverardi L, Ricordi C. Stem cell-derived islet cells for transplantation. Curr Opin Organ Transplant 2011;16:76-82. [PMID: 21150613 DOI: 10.1097/MOT.0b013e32834252b5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
317 Soares MBP, Santos RRD. Current status and perspectives of cell therapy in Chagas disease. Mem Inst Oswaldo Cruz 2009;104:325-32. [DOI: 10.1590/s0074-02762009000900043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
318 Barminko J, Kim JH, Otsuka S, Gray A, Schloss R, Grumet M, Yarmush ML. Encapsulated mesenchymal stromal cells for in vivo transplantation. Biotechnol Bioeng 2011;108:2747-58. [PMID: 21656712 DOI: 10.1002/bit.23233] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
319 Gugjoo MB, Hussain S, Amarpal, Shah RA, Dhama K. Mesenchymal Stem Cell-Mediated Immuno-Modulatory and Anti- Inflammatory Mechanisms in Immune and Allergic Disorders. Recent Pat Inflamm Allergy Drug Discov 2020;14:3-14. [PMID: 32000656 DOI: 10.2174/1872213X14666200130100236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
320 Alstrup T, Eijken M, Brunbjerg ME, Hammer-Hansen N, Møller BK, Damsgaard TE. Measured Levels of Human Adipose Tissue-Derived Stem Cells in Adipose Tissue Is Strongly Dependent on Harvesting Method and Stem Cell Isolation Technique. Plast Reconstr Surg 2020;145:142-50. [PMID: 31881616 DOI: 10.1097/PRS.0000000000006404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
321 Martínez-Montiel Mdel P, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol. 2014;20:1211-1227. [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
322 Kota DJ, Prabhakara KS, Cox CS, Olson SD. MSCs and hyaluronan: Sticking together for new therapeutic potential? The International Journal of Biochemistry & Cell Biology 2014;55:1-10. [DOI: 10.1016/j.biocel.2014.07.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
323 Wang L, Weiss ML, Detamore MS. Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells. Recent Pat Regen Med 2013;3:182-92. [PMID: 26279972 DOI: 10.2174/22102965113039990020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
324 Zweigerdt R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 2009;114:201-35. [PMID: 19513633 DOI: 10.1007/10_2008_27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
325 Lamichhane SP, Arya N, Kohler E, Xiang S, Christensen J, Shastri VP. Recapitulating epithelial tumor microenvironment in vitro using three dimensional tri-culture of human epithelial, endothelial, and mesenchymal cells. BMC Cancer 2016;16:581. [PMID: 27484993 DOI: 10.1186/s12885-016-2634-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
326 Baiguera S, Jungebluth P, Mazzanti B, Macchiarini P. Mesenchymal stromal cells for tissue-engineered tissue and organ replacements. Transpl Int 2012;25:369-82. [PMID: 22248229 DOI: 10.1111/j.1432-2277.2011.01426.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
327 Aluri HS, Samizadeh M, Edman MC, Hawley DR, Armaos HL, Janga SR, Meng Z, Sendra VG, Hamrah P, Kublin CL, Hamm-Alvarez SF, Zoukhri D. Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjögren's Syndrome. Stem Cells Int 2017;2017:3134543. [PMID: 28348600 DOI: 10.1155/2017/3134543] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
328 Tsai YA, Liu RS, Lirng JF, Yang BH, Chang CH, Wang YC, Wu YS, Ho JH, Lee OK, Soong BW. Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study. Cell Transplant 2017;26:503-12. [PMID: 28195034 DOI: 10.3727/096368916X694373] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
329 Meretoja VV, Tirri T, Malin M, Seppälä JV, Närhi TO. Ectopic bone formation in and soft-tissue response to P(CL/DLLA)/bioactive glass composite scaffolds. Clin Oral Impl Res 2014;25:159-64. [DOI: 10.1111/clr.12051] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
330 Marzouni ET, Dorcheh SP, Nejad-Moghaddam A, Ghanei M, Goodarzi H, Hosseini SE, Madani H. Adipose-derived mesenchymal stem cells ameliorate lung epithelial injury through mitigating of oxidative stress in mustard lung. Regen Med 2020. [PMID: 32935623 DOI: 10.2217/rme-2020-0051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Acosta SA, Tajiri N, Hoover J, Kaneko Y, Borlongan CV. Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke. Stroke. 2015;46:2616-2627. [PMID: 26219646 DOI: 10.1161/strokeaha.115.009854] [Cited by in Crossref: 112] [Cited by in F6Publishing: 70] [Article Influence: 18.7] [Reference Citation Analysis]
332 Guan LX, Guan H, Li HB, Ren CA, Liu L, Chu JJ, Dai LJ. Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes. Exp Ther Med. 2015;9:1623-1630. [PMID: 26136869 DOI: 10.3892/etm.2015.2339] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
333 Zeng SL, Wang LH, Li P, Wang W, Yang J. Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol Med Rep 2015;12:2511-20. [PMID: 25936350 DOI: 10.3892/mmr.2015.3706] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
334 Sadeghi B, Heshmati Y, Khoein B, Kaipe H, Uzunel M, Walfridsson J, Ringdén O. Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo. Cytotherapy 2015;17:1732-45. [DOI: 10.1016/j.jcyt.2015.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
335 Ringdén O. Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease and Graft Failure After Hematopoietic Stem Cell Transplantation and Future Challenges. In: Chase LG, Vemuri MC, editors. Mesenchymal Stem Cell Therapy. Totowa: Humana Press; 2013. pp. 173-205. [DOI: 10.1007/978-1-62703-200-1_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
336 Fawzy SA, El-Din Abo-Elnou RK, Abd-El-Maksoud El-Deeb DF, Yousry Abd-Elkader MM. The possible role of mesenchymal stem cells therapy in the repair of experimentally induced colitis in male albino rats. Int J Stem Cells 2013;6:92-103. [PMID: 24386553 DOI: 10.15283/ijsc.2013.6.2.92] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
337 Gimble JM, Guilak F, Nuttall ME, Sathishkumar S, Vidal M, Bunnell BA. In vitro Differentiation Potential of Mesenchymal Stem Cells. Transfus Med Hemother. 2008;35:228-238. [PMID: 21547120 DOI: 10.1159/000124281] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
338 Krishnan R, Ko D, Foster CE, Liu W, Smink AM, de Haan B, De Vos P, Lakey JR. Immunological Challenges Facing Translation of Alginate Encapsulated Porcine Islet Xenotransplantation to Human Clinical Trials. Methods Mol Biol. 2017;1479:305-333. [PMID: 27738946 DOI: 10.1007/978-1-4939-6364-5_24] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
339 Popp FC, Renner P, Eggenhofer E, Slowik P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl. 2009;15:1192-1198. [PMID: 19790154 DOI: 10.1002/lt.21862] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
340 Li T, Ma H, Ma H, Ma Z, Qiang L, Yang Z, Yang X, Zhou X, Dai K, Wang J. Mussel-Inspired Nanostructures Potentiate the Immunomodulatory Properties and Angiogenesis of Mesenchymal Stem Cells. ACS Appl Mater Interfaces 2019;11:17134-46. [DOI: 10.1021/acsami.8b22017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
341 Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective. Hum Cell. 2020;33:907-918. [PMID: 32780299 DOI: 10.1007/s13577-020-00407-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
342 Fernández Vallone VB, Romaniuk MA, Choi H, Labovsky V, Otaegui J, Chasseing NA. Mesenchymal stem cells and their use in therapy: what has been achieved? Differentiation 2013;85:1-10. [PMID: 23314286 DOI: 10.1016/j.diff.2012.08.004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]
343 Voswinkel J, Chapel A. [Mesenchymal stem cells and rheumatism. State of the art]. Z Rheumatol. 2012;71:619-623. [PMID: 22825552 DOI: 10.1007/s00393-011-0950-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
344 Uder C, Brückner S, Winkler S, Tautenhahn HM, Christ B. Mammalian MSC from selected species: Features and applications. Cytometry A 2018;93:32-49. [PMID: 28906582 DOI: 10.1002/cyto.a.23239] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
345 Mello DB, Ramos IP, Mesquita FC, Brasil GV, Rocha NN, Takiya CM, Lima AP, Campos de Carvalho AC, Goldenberg RS, Carvalho AB. Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity. PLoS Negl Trop Dis 2015;9:e0003945. [PMID: 26248209 DOI: 10.1371/journal.pntd.0003945] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
346 Bittencourt MK, Barros MA, Martins JF, Vasconcellos JP, Morais BP, Pompeia C, Bittencourt MD, Evangelho KD, Kerkis I, Wenceslau CV. Allogeneic Mesenchymal Stem Cell Transplantation in Dogs With Keratoconjunctivitis Sicca. Cell Med 2016;8:63-77. [PMID: 28003932 DOI: 10.3727/215517916X693366] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
347 Boshuizen MCS, Steinberg GK. Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes. Stroke 2018;49:1563-70. [PMID: 29724892 DOI: 10.1161/STROKEAHA.117.020465] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
348 Becerra J, Duran I. Inflammation, a common mechanism in frailty and COVID19, and stem cells as a therapeutic approach. Stem Cells Transl Med 2021. [PMID: 34164948 DOI: 10.1002/sctm.21-0074] [Reference Citation Analysis]
349 Paul D, Samuel SM, Maulik N. Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. Antioxid Redox Signal 2009;11:1841-55. [PMID: 19260767 DOI: 10.1089/ars.2009.2455] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
350 Ho JH, Tseng TC, Ma WH, Ong WK, Chen YF, Chen MH, Lin MW, Hong CY, Lee OK. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice. Cell Transplant 2012;21:997-1009. [PMID: 22004871 DOI: 10.3727/096368911X603611] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
351 Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, Ilan AB, Bulvik S, Shemesh N, Krepel D, Cohen Y, Melamed E, Offen D. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev. 2009;18:1179-1190. [PMID: 19243240 DOI: 10.1089/scd.2008.0411] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 8.3] [Reference Citation Analysis]
352 Najimi M, Berardis S, El-Kehdy H, Rosseels V, Evraerts J, Lombard C, El Taghdouini A, Henriet P, van Grunsven L, Sokal EM. Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation. Stem Cell Res Ther 2017;8:131. [PMID: 28583205 DOI: 10.1186/s13287-017-0575-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
353 Pei M, He F, Li J, Tidwell JE, Jones AC, McDonough EB. Repair of large animal partial-thickness cartilage defects through intraarticular injection of matrix-rejuvenated synovium-derived stem cells. Tissue Eng Part A 2013;19:1144-54. [PMID: 23216161 DOI: 10.1089/ten.TEA.2012.0351] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
354 Guo Q, Wang J. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury. Immunopharmacol Immunotoxicol 2018;40:168-72. [PMID: 29355065 DOI: 10.1080/08923973.2018.1424898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
355 Hejretová L, Čedíková M, Dolejšová M, Vlas T, Jindra P, Lysák D, Holubová M. Comparison of the immunomodulatory effect of single MSC batches versus pooled MSC products. Cell Tissue Bank 2020;21:119-29. [PMID: 31863261 DOI: 10.1007/s10561-019-09805-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
356 Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:180-192. [PMID: 23296948 DOI: 10.1007/s12016-012-8347-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 11.3] [Reference Citation Analysis]
357 Sullivan R, Dailey T, Duncan K, Abel N, Borlongan CV. Peripheral Nerve Injury: Stem Cell Therapy and Peripheral Nerve Transfer. Int J Mol Sci. 2016;17. [PMID: 27983642 DOI: 10.3390/ijms17122101] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 14.4] [Reference Citation Analysis]
358 Chien M, Bien M, Ku C, Chang Y, Pao H, Yang Y, Hsiao M, Chen C, Ho JH. Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury: . Critical Care Medicine 2012;40:1245-53. [DOI: 10.1097/ccm.0b013e31823bc89a] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
359 Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A. Stem cell platforms for regenerative medicine. Clin Transl Sci. 2009;2:222-227. [PMID: 19779576 DOI: 10.1111/j.1752-8062.2009.00096.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
360 Martínez-Peinado P, Pascual-García S, Roche E, Sempere-Ortells JM. Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets. J Immunol Res 2018;2018:7232717. [PMID: 30271793 DOI: 10.1155/2018/7232717] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
361 Sundelacruz S, Levin M, Kaplan DL. Comparison of the depolarization response of human mesenchymal stem cells from different donors. Sci Rep 2015;5:18279. [PMID: 26658512 DOI: 10.1038/srep18279] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
362 Sharpe ME, Morton D, Rossi A. Nonclinical safety strategies for stem cell therapies. Toxicol Appl Pharmacol 2012;262:223-31. [PMID: 22617430 DOI: 10.1016/j.taap.2012.05.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
363 Forrester JV, Steptoe RJ, Klaska IP, Martin-Granados C, Dua HS, Degli-Esposti MA, Wikstrom ME. Cell-based therapies for ocular inflammation. Prog Retin Eye Res. 2013;35:82-101. [PMID: 23542232 DOI: 10.1016/j.preteyeres.2013.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
364 Badiavas AR, Badiavas EV. Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing. Expert Opin Biol Ther 2011;11:1447-54. [PMID: 21854302 DOI: 10.1517/14712598.2011.606212] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
365 Tatara R, Ozaki K, Kikuchi Y, Hatanaka K, Oh I, Meguro A, Matsu H, Sato K, Ozawa K. Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation. Cytotherapy 2011;13:686-94. [DOI: 10.3109/14653249.2010.542456] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
366 Rodas G, Soler R, Balius R, Alomar X, Peirau X, Alberca M, Sánchez A, Sancho JG, Rodellar C, Romero A, Masci L, Orozco L, Maffulli N. Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: protocol for a phase I/II, single-centre, randomized with active control PRP, double-blinded clinical trial. J Orthop Surg Res 2019;14:441. [PMID: 31842921 DOI: 10.1186/s13018-019-1477-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
367 Cohen JD, Kanim LE, Tronits AJ, Bae HW. Allografts and Spinal Fusion. Int J Spine Surg 2021;15:68-93. [PMID: 34376497 DOI: 10.14444/8056] [Reference Citation Analysis]
368 Stamm C, Nasseri B, Drews T, Hetzer R. Cardiac cell therapy: A realistic concept for elderly patients? Experimental Gerontology 2008;43:679-90. [DOI: 10.1016/j.exger.2008.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
369 Pan Q, Li Q, Liu S, Ning N, Zhang X, Xu Y, Chang AE, Wicha MS. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches. Stem Cells. 2015;33:2085-2092. [PMID: 25873269 DOI: 10.1002/stem.2039] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 14.5] [Reference Citation Analysis]
370 Longoni B, Szilagyi E, Quaranta P, Paoli GT, Tripodi S, Urbani S, Mazzanti B, Rossi B, Fanci R, Demontis GC. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation. Diabetes Technol Ther. 2010;12:435-446. [PMID: 20470228 DOI: 10.1089/dia.2009.0154] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
371 Allen RJ Jr, Canizares O Jr, Scharf C, Nguyen PD, Thanik V, Saadeh PB, Coleman SR, Hazen A. Grading lipoaspirate: is there an optimal density for fat grafting? Plast Reconstr Surg 2013;131:38-45. [PMID: 23271517 DOI: 10.1097/PRS.0b013e3182729cc6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
372 Sánchez-Abarca LI, Alvarez-Laderas I, Díez Campelo M, Caballero-Velázquez T, Herrero C, Muntión S, Calderón C, García-Guerrero E, Sánchez-Guijo F, Del Cañizo C, San Miguel J, Pérez-Simón JA. Uptake and delivery of antigens by mesenchymal stromal cells. Cytotherapy 2013;15:673-8. [PMID: 23522868 DOI: 10.1016/j.jcyt.2013.01.216] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
373 Fändrich F. Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation. Current Opinion in Organ Transplantation 2010;15:703-8. [DOI: 10.1097/mot.0b013e328340669a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
374 Sanchez C, Oskowitz A, Pochampally RR. Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells. Stem Cells 2009;27:375-82. [PMID: 19038795 DOI: 10.1634/stemcells.2008-0546] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
375 Fitzpatrick E, Mitry RR, Dhawan A. Human hepatocyte transplantation: state of the art. J Intern Med. 2009;266:339-357. [PMID: 19765179 DOI: 10.1111/j.1365-2796.2009.02152.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 8.8] [Reference Citation Analysis]
376 Kuraitis D, Ruel M, Suuronen EJ. Mesenchymal stem cells for cardiovascular regeneration. Cardiovasc Drugs Ther 2011;25:349-62. [PMID: 21637968 DOI: 10.1007/s10557-011-6311-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
377 Bruck F, Belle L, Lechanteur C, de Leval L, Hannon M, Dubois S, Castermans E, Humblet-baron S, Rahmouni S, Beguin Y, Briquet A, Baron F. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy 2013;15:267-79. [DOI: 10.1016/j.jcyt.2012.09.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
378 Zhang H, Chen Z, Bie P. Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: a review of current data. Transfus Med Rev 2012;26:129-41. [PMID: 22015073 DOI: 10.1016/j.tmrv.2011.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
379 Choi YH, Saric T, Nasseri B, Hühn S, Van Linthout S, Hetzer R, Tschöpe C, Stamm C. Cardiac cell therapies: the next generation. Cardiovasc Ther 2011;29:2-16. [PMID: 20946322 DOI: 10.1111/j.1755-5922.2010.00191.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
380 Ichim TE, Harman RJ, Min W, Minev B, Solano F, Rodriguez JP, Alexandrescu DT, De Necochea-campion R, Hu X, Marleau AM, Riordan NH. Autologous stromal vascular fraction cells: A tool for facilitating tolerance in rheumatic disease. Cellular Immunology 2010;264:7-17. [DOI: 10.1016/j.cellimm.2010.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
381 Labibzadeh N, Emadedin M, Fazeli R, Mohseni F, Hosseini SE, Moghadasali R, Mardpour S, Azimian V, Ghorbani Liastani M, Mirazimi Bafghi A, Baghaban Eslaminejad M, Aghdami N. Mesenchymal Stromal Cells Implantation in Combination with Platelet Lysate Product Is Safe for Reconstruction of Human Long Bone Nonunion.Cell J. 2016;18:302-309. [PMID: 27602311 DOI: 10.22074/cellj.2016.4557] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
382 Denu RA, Hematti P. Optimization of oxidative stress for mesenchymal stromal/stem cell engraftment, function and longevity. Free Radic Biol Med 2021;167:193-200. [PMID: 33677063 DOI: 10.1016/j.freeradbiomed.2021.02.042] [Reference Citation Analysis]
383 Mishra PJ, Mishra PJ, Banerjee D. Cell-free derivatives from mesenchymal stem cells are effective in wound therapy. World J Stem Cells 2012;4:35-43. [PMID: 22993660 DOI: 10.4252/wjsc.v4.i5.35] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
384 Najar M, Raicevic G, Boufker HI, Fayyad-Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A 2010;16:3537-46. [PMID: 20597819 DOI: 10.1089/ten.TEA.2010.0159] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
385 Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells 2020;12:277-87. [PMID: 32399136 DOI: 10.4252/wjsc.v12.i4.277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
386 Hagmann S, Gotterbarm T, Müller T, Baesig AM, Gantz S, Dreher T, Kämmerer PW, Frank S, Zeifang F, Moradi B. The influence of bone marrow- and synovium-derived mesenchymal stromal cells from osteoarthritis patients on regulatory T cells in co-culture. Clin Exp Immunol 2013;173:454-62. [PMID: 23607395 DOI: 10.1111/cei.12122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
387 Bianco P, Robey PG, Saggio I, Riminucci M. “Mesenchymal” stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther. 2010;21:1057-1066. [PMID: 20649485 DOI: 10.1089/hum.2010.136] [Cited by in Crossref: 120] [Cited by in F6Publishing: 105] [Article Influence: 10.9] [Reference Citation Analysis]
388 de Mare-Bredemeijer EL, Mancham S, Verstegen MM, de Ruiter PE, van Gent R, O'Neill D, Tilanus HW, Metselaar HJ, de Jonge J, Kwekkeboom J, Hall SR, van der Laan LJ. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses. Stem Cells Dev 2015;24:1436-47. [PMID: 25744002 DOI: 10.1089/scd.2014.0485] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
389 Lepperdinger G, Brunauer R, Gassner R, Jamnig A, Kloss F, Laschober GT. Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment. Transfus Med Hemother 2008;35:299-305. [PMID: 21512646 DOI: 10.1159/000142373] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
390 Cras A, Farge D, Carmoi T, Lataillade JJ, Wang DD, Sun L. Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res Ther 2015;17:301. [PMID: 26525582 DOI: 10.1186/s13075-015-0819-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 8.3] [Reference Citation Analysis]
391 Sevim H, Kocaefe YÇ, Onur MA, Uçkan-Çetinkaya D, Gürpınar ÖA. Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2. Stem Cell Res Ther 2018;9:198. [PMID: 30021624 DOI: 10.1186/s13287-018-0941-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
392 Zhang Y, Dou Z. Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study. Stem Cell Res Ther. 2014;5:66. [PMID: 24887638 DOI: 10.1186/scrt455] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
393 Sudres M, Maurer M, Robinet M, Bismuth J, Truffault F, Girard D, Dragin N, Attia M, Fadel E, Santelmo N, Sicsic C, Brenner T, Berrih-Aknin S. Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model. JCI Insight 2017;2:e89665. [PMID: 28405609 DOI: 10.1172/jci.insight.89665] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
394 Parekkadan B, Tilles AW, Yarmush ML. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells. 2008;26:1913-1919. [PMID: 18420833 DOI: 10.1634/stemcells.2007-0790] [Cited by in Crossref: 114] [Cited by in F6Publishing: 108] [Article Influence: 8.8] [Reference Citation Analysis]
395 Hagmann S, Moradi B, Frank S, Dreher T, Kämmerer PW, Richter W, Gotterbarm T. FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential. Cell Prolif 2013;46:396-407. [PMID: 23869761 DOI: 10.1111/cpr.12046] [Cited by in F6Publishing: 36] [Reference Citation Analysis]
396 Kot M, Baj-Krzyworzeka M, Szatanek R, Musiał-Wysocka A, Suda-Szczurek M, Majka M. The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies. Int J Mol Sci 2019;20:E5680. [PMID: 31766164 DOI: 10.3390/ijms20225680] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
397 Holan V, Hermankova B, Bohacova P, Kossl J, Chudickova M, Hajkova M, Krulova M, Zajicova A, Javorkova E. Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment. Stem Cell Rev Rep. 2016;12:654-663. [PMID: 27665290 DOI: 10.1007/s12015-016-9688-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
398 Seiffert N, Tang P, Keshi E, Reutzel-Selke A, Moosburner S, Everwien H, Wulsten D, Napierala H, Pratschke J, Sauer IM, Hillebrandt KH, Struecker B. In vitro recellularization of decellularized bovine carotid arteries using human endothelial colony forming cells. J Biol Eng 2021;15:15. [PMID: 33882982 DOI: 10.1186/s13036-021-00266-5] [Reference Citation Analysis]
399 Kim JS, Lee JH, Kwon O, Cho JH, Choi JY, Park SH, Kim CD, Kim YJ, Kim YL. Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy. Kidney Res Clin Pract 2017;36:200-4. [PMID: 28680828 DOI: 10.23876/j.krcp.2017.36.2.200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
400 Chen X, Shao H, Zhi Y, Xiao Q, Su C, Dong L, Liu X, Li X, Zhang X. CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses. Stem Cells Dev. 2016;25:337-346. [PMID: 26650818 DOI: 10.1089/scd.2015.0227] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
401 Mao F, Kang JJ, Cai X, Ding NF, Wu YB, Yan YM, Qian H, Zhang X, Xu WR. Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemp Oncol (Pozn) 2017;21:91-7. [PMID: 28947877 DOI: 10.5114/wo.2017.68616] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
402 Alipour R, Adib M, Hashemi-Beni B, Sadeghi F. The effect of stem cell from human exfoliated deciduous teeth on T lymphocyte proliferation. Adv Biomed Res 2014;3:202. [PMID: 25337532 DOI: 10.4103/2277-9175.142312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
403 Stock P, Brückner S, Winkler S, Dollinger MM, Christ B. Human bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury. Int J Mol Sci 2014;15:7004-28. [PMID: 24758938 DOI: 10.3390/ijms15047004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
404 Pérez-Simón JA, Tabera S, Sarasquete ME, Díez-Campelo M, Canchado J, Sánchez-Abarca LI, Blanco B, Alberca I, Herrero-Sánchez C, Cañizo C, San Miguel JF. Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy 2009;11:698-705. [PMID: 19878056 DOI: 10.3109/14653240903051558] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
405 de Wolf C, van de Bovenkamp M, Hoefnagel M. Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy. Cytotherapy 2017;19:784-97. [PMID: 28457740 DOI: 10.1016/j.jcyt.2017.03.076] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
406 Kang KN, Kim da Y, Yoon SM, Lee JY, Lee BN, Kwon JS, Seo HW, Lee IW, Shin HC, Kim YM. Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells. Biomaterials. 2012;33:4828-4835. [PMID: 22498301 DOI: 10.1016/j.biomaterials.2012.03.043] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
407 Holan V, Pokorna K, Prochazkova J, Krulova M, Zajicova A. Immunoregulatory properties of mouse limbal stem cells. J Immunol 2010;184:2124-9. [PMID: 20065115 DOI: 10.4049/jimmunol.0903049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
408 Costa de Oliveira Souza CM, de Souza CF, Mogharbel BF, Irioda AC, Cavichiolo Franco CR, Sierakowski MR, Athayde Teixeira de Carvalho K. Nanostructured Cellulose-Gellan-Xyloglucan-Lysozyme Dressing Seeded with Mesenchymal Stem Cells for Deep Second-Degree Burn Treatment. Int J Nanomedicine 2021;16:833-50. [PMID: 33584096 DOI: 10.2147/IJN.S289868] [Reference Citation Analysis]
409 Donders R, Bogie JF, Ravanidis S, Gervois P, Vanheusden M, Marée R, Schrynemackers M, Smeets HJ, Pinxteren J, Gijbels K, Walbers S, Mays RW, Deans R, Van Den Bosch L, Stinissen P, Lambrichts I, Gyselaers W, Hellings N. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells. Stem Cells and Development 2018;27:65-84. [DOI: 10.1089/scd.2017.0029] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
410 Rahimzadeh A, Mirakabad FS, Movassaghpour A, Shamsasenjan K, Kariminekoo S, Talebi M, Shekari A, Zeighamian V, Ghalhar MG, Akbarzadeh A. Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system.Artif Cells Nanomed Biotechnol. 2016;44:559-570. [PMID: 25340260 DOI: 10.3109/21691401.2014.968823] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
411 Puglisi MA, Tesori V, Lattanzi W, Piscaglia AC, Gasbarrini GB, D'Ugo DM, Gasbarrini A. Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol. 2011;2011:860578. [PMID: 22228987 DOI: 10.1155/2011/860578] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
412 Jung S, Sen A, Rosenberg L, Behie LA. Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 2010;12:637-57. [PMID: 20608762 DOI: 10.3109/14653249.2010.495113] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
413 Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal Stromal Cells: A Novel Treatment Modality for Tissue Repair. Annals of the New York Academy of Sciences 2009;1176:101-17. [DOI: 10.1111/j.1749-6632.2009.04607.x] [Cited by in Crossref: 213] [Cited by in F6Publishing: 183] [Article Influence: 17.8] [Reference Citation Analysis]
414 Madigan M, Atoui R. Therapeutic Use of Stem Cells for Myocardial Infarction. Bioengineering (Basel) 2018;5:E28. [PMID: 29642402 DOI: 10.3390/bioengineering5020028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
415 Bernardo ME, Locatelli F. Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation. Methods Mol Biol 2016;1416:3-20. [PMID: 27236663 DOI: 10.1007/978-1-4939-3584-0_1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
416 Zou Z, Zhang Y, Hao L, Wang F, Liu D, Su Y, Sun H. More insight into mesenchymal stem cells and their effects inside the body. Expert Opin Biol Ther. 2010;10:215-230. [PMID: 20088716 DOI: 10.1517/14712590903456011] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
417 García-fernández C, López-fernández A, Borrós S, Lecina M, Vives J. Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells. Biochemical Engineering Journal 2020;159:107601. [DOI: 10.1016/j.bej.2020.107601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
418 Christ B, Dollinger MM. The generation of hepatocytes from mesenchymal stem cells and engraftment into the liver. Curr Opin Organ Transplant. 2011;16:69-75. [PMID: 21150616 DOI: 10.1097/mot.0b013e3283424f5b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
419 Muraca M, Pessina A, Pozzobon M, Dominici M, Galderisi U, Lazzari L, Parolini O, Lucarelli E, Perilongo G, Baraldi E. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? J Control Release 2020;325:135-40. [PMID: 32622963 DOI: 10.1016/j.jconrel.2020.06.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
420 Xu B, Chen SS, Liu MZ, Gan CX, Li JQ, Guo GH. Stem cell derived exosomes-based therapy for acute lung injury and acute respiratory distress syndrome: A novel therapeutic strategy. Life Sci 2020;254:117766. [PMID: 32418895 DOI: 10.1016/j.lfs.2020.117766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
421 Kim J, Shapiro L, Flynn A. The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease. Pharmacology & Therapeutics 2015;151:8-15. [DOI: 10.1016/j.pharmthera.2015.02.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 8.7] [Reference Citation Analysis]
422 Amemori T, Jendelová P, Růzicková K, Arboleda D, Syková E. Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. Cytotherapy 2010;12:212-25. [PMID: 20196694 DOI: 10.3109/14653240903440103] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
423 Kiernan CH, Wolvius EB, Brama PA, Farrell E. The Immune Response to Allogeneic Differentiated Mesenchymal Stem Cells in the Context of Bone Tissue Engineering. Tissue Engineering Part B: Reviews 2018;24:75-83. [DOI: 10.1089/ten.teb.2017.0175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
424 Skovrlj B, Guzman JZ, Al Maaieh M, Cho SK, Iatridis JC, Qureshi SA. Cellular bone matrices: viable stem cell-containing bone graft substitutes. Spine J. 2014;14:2763-2772. [PMID: 24929059 DOI: 10.1016/j.spinee.2014.05.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
425 Mansilla E, Díaz Aquino V, Zambón D, Marin GH, Mártire K, Roque G, Ichim T, Riordan NH, Patel A, Sturla F. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes? Stem Cells Int. 2011;2011:943216. [PMID: 21716667 DOI: 10.4061/2011/943216] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
426 Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009;4:62-72. [PMID: 19128793 DOI: 10.1016/j.stem.2008.10.017] [Cited by in Crossref: 217] [Cited by in F6Publishing: 198] [Article Influence: 18.1] [Reference Citation Analysis]
427 Vittorio O, Quaranta P, Raffa V, Funel N, Campani D, Pelliccioni S, Longoni B, Mosca F, Pietrabissa A, Cuschieri A. Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields. Nanomedicine (Lond) 2011;6:43-54. [PMID: 21182417 DOI: 10.2217/nnm.10.125] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
428 Andorko JI, Jewell CM. Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine. Bioeng Transl Med 2017;2:139-55. [PMID: 28932817 DOI: 10.1002/btm2.10063] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 22.5] [Reference Citation Analysis]
429 Schneider C, Krause K, Jaquet K, Geidel S, Malisius R, Boczor S, Rau T, Zienkiewicz T, Hennig D, Kuck KH. Intramyocardial transplantation of bone marrow-derived stem cells: ultrasonic strain rate imaging in a model of hibernating myocardium. J Card Fail 2008;14:861-72. [PMID: 19041051 DOI: 10.1016/j.cardfail.2008.08.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
430 Buja LM, Vela D. Immunologic and Inflammatory Reactions to Exogenous Stem Cells. Journal of the American College of Cardiology 2010;56:1693-700. [DOI: 10.1016/j.jacc.2010.06.041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
431 Zhu HX, Gao JL, Zhao MM, Li R, Tian YX, Wang X, Zhang J, Yuan JX, Cui JZ. Effects of bone marrow-derived mesenchymal stem cells on the autophagic activity of alveolar macrophages in a rat model of silicosis. Exp Ther Med 2016;11:2577-82. [PMID: 27284351 DOI: 10.3892/etm.2016.3200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
432 Chen CW, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L, Péault B. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 2009;20:429-34. [PMID: 19926515 DOI: 10.1016/j.cytogfr.2009.10.014] [Cited by in Crossref: 113] [Cited by in F6Publishing: 111] [Article Influence: 10.3] [Reference Citation Analysis]